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Sea buckthorn (Hippophaë) berries are ingredients of the Chinese traditional 
medicine. In addition to China, they are nowadays cultivated for food in several 
European countries, Russia, Canada, the USA, and Japan. Sea buckthorn berries 
are a rich source of flavonoids, mainly flavonol glycosides and proanthocyanidins. 
Depending on the genetic background, growth conditions, and ripeness of the 
berries, vitamin C concentrations up to over 1 g/100 ml juice, have been reported. 
Sea buckthorn berries contain inositols and methyl inositols, components of 
messenger molecules in humans. Sea buckthorn seed oil is rich in essential α-
linolenic and linoleic acids, whereas the most abundant fatty acids in the berry oil 
are palmitoleic, palmitic and oleic acids. Other potentially beneficial lipophilic 
compounds of sea buckthorn seeds and berries include carotenoids, phytosterols, 
tocopherols and tocotrienols.  
The effects of sea buckthorn fractions on inflammation, platelet aggregation, 
oxidation injuries, the liver, skin and mucosa, among others, have been reported. 
The aim of the thesis work was to investigate the health effects of sea buckthorn 
berries and oil in humans. The physiological effects of sea buckthorn berries, berry 
components, and oil have mostly been studied in vitro and in animal models, 
leaving a demand for more clinical trials.  
In the first randomized, placebo-controlled trial of this thesis healthy adults 
consumed 28 g/day of sea buckthorn berries for three months. The main objective 
was to investigate the effects on the common cold. In addition, effects on other 
infections, inflammation and circulating lipid markers associated with 
cardiovascular disease risk were studied. In the second randomized, placebo-
controlled trial participants reporting dry eye symptoms consumed 2 g/day of sea 
buckthorn oil from the seeds and berries for three months. The effects on 
symptoms and clinical signs of dry eye were monitored. In addition, the effects on 
circulating markers of inflammation and liver functions were analyzed.  
Sea buckthorn berries did not affect the common cold or other infections in healthy 
adults. However, a decrease in serum C-reactive protein was detected, indicating 
effects on inflammation. Fasting concentrations of serum flavonols, typical to sea 
buckthorn berry, increased without affecting the circulating total, HDL, LDL 
cholesterol, or triacylglycerol concentrations.  
Tear film hyperosmolarity and activation of inflammation at the ocular surface are 
among the core mechanisms of dry eye. Combined sea buckthorn berry and seed oil 
attenuated the rise in tear film osmolarity taking place during the cold season. It also 
positively affected some of the dry eye symptoms. Based on the tear film fatty acid 
analysis, the effects were not mediated through direct incorporation of sea buckthorn 
oil fatty acids to tear film lipids. It is likely that the fatty acids, carotenoids, tocopherols 
and tocotrienols of sea buckthorn oil affected the inflammation of the ocular surface, 
lacrimal and/or meibomian glands. The effects on the differentiation of meibomian 
gland cells are also possible. Sea buckthorn oil did not affect the serum concentrations 
of inflammation markers or liver enzymes investigated.  
In conclusion, this thesis work suggests positive effects of sea buckthorn berries 
and oil on inflammation and dry eye, respectively, in humans.  
List of Abbreviations 
 
6 
LIST OF ABBREVIATIONS 
ADP  adenosine diphosphate 
AI   atherogenic index  
ALAT  alanine aminotransferase 
ANCOVA analysis of covariance 
ANOVA analysis of variance 
ASAT  aspartate aminotransferase 
BHT  butylated hydroxytoluene 
bw  body weight 
cAMP  cyclic adenosine mono phosphate 
CI  confidence interval  
COX  cyclo-oxygenase 
CRP  C-reactive protein 
DFO  deferoxamine 
DNA  deoxyribonucleic acid 
DPPH  1,1-diphenyl-2-picry hydrazyl 
eNOS  endothelial constitutive nitric oxide synthase 
extr.  extract 
FID  flame ionization detector 
GPx  glutathione peroxidase 
GSH  glutathione 
GSH-Px glutathione peroxidase   
GSH-Rd glutathione reducatase   
GT  γ-glutamyl aminotransferase 
HDL  high density lipoprotein 
hex  hexane 
HPLC  high performance liquid chromatography  
i.g.   intragastric  
i.p.   intraperitonial  
IU  international unit   
i.v.  intravenous  
ICAM-1 intracellular adhesion molecule-1 
IgE  immunoglobulin E 
IL-6  interleukin-6 
iNOS  inducible nitric oxide synthase 
IRF-1  interferon regulatory factor-1 
LDH   lactate dehydrogenase 
LDL  low-density lipoprotein 
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LOX  lipoxygenase 
LOX-1   lectinlike low density lipoprotein receptor-1 
MAPK  mitogen activated protein kinase 
MDA   malonialdehyde 
mOSDI modified Ocular Surface Disease Index 
NF-kB  nuclear factor-kB 
NL  neutral lipid 
NO  nitric oxide 
NOAEL No Observed Adverse Effect Level 
OEA  oleoylethanolamide 
ox-LDL oxidized low density lipoprotein 
PAE  N-palmitoyl ethanolamide 
PBMC  peripheral blood mononuclear cell  
PG   propylene glycol 
PKA  protein kinase A, cAMP-dependent protein kinase 
PL  phospholipid  
PPARγ peroxisome proliferator-activated receptor γ 
REA  retinol activity equivalent 
RNS  reactive nitrogen species 
ROO∙  peroxyl radical 
ROS  reactive oxygen species 
RR  relative risk 
sb  sea buckthorn 
ssp.  subspecies 
SCORAD SCORing Atopic Dermatitis 
SNP  sodium nitroprusside 
SOD  superoxide dismutase 
SS   Sjögren’s syndrome   
STZ  streptozotocin 
TAG  triacylglycerol 
t-BOOH tert-butyl hydroperoxide 
TBARS thiobarbituric acid reactive substances 
TBUT  tear film break-up time 
TNF-α  tumor necrosis factor-α 
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The seven species of the small genus Hippophaë, family Elaeagnaceae, are called 
sea buckthorn. Hippophaë rhamnoides is geographically the most widely 
distributed species [204]. It is also the most variable one having eight 
subspecies (ssp.), including the commercially important ssp. sinensis (Chinese 
subspecies), ssp. rhamnoides (European) and ssp. mongolica (Russian) [204, 238]. 
The other rarer species grow in high altitudinal areas in China, Tibet and 
Nepal [204]. In addition to the naturally growing species and subspecies of sea 
buckthorn, several commercial varieties and cultivars exist [36, 204, 238].  
Sea buckthorn has been used in Eastern traditional medicine for centuries. In 
the Chinese Pharmacopeia, sea buckthorn berries are prescribed for relieving 
cough and for promoting digestion and blood circulation [39]. In Central 
Nepal, where only few people have access to modern medicine, sea buckthorn 
is among the medicinal plants with the widest spectra of use indications [217]. 
These include cough, diarrhoea, menstrual, and stomach disorders [217]. 
Nowadays it is known that sea buckthorn berries and leaves are rich in 
bioactive compounds, and their health effects are studied scientifically. A 
considerable number of studies have been carried out in China, Russia, and 
other Asian countries and are not published in English.  
Despite their use in traditional medicine, sea buckthorn berries are food rather 
than drugs. In Europe they are consumed as juices, jams and food ingredients 
in domestic cooking and by the food industry. Sea buckthorn fractions, 
including oils and flavonoids are used as dietary supplements and ingredients 
in cosmetics. Although the definitions of food and drug may ovelap, 
supplements are in general classified as food in the European Union [19, 71]. A 
supplement may be defined as medicine if it has a modifying effect on 
physiological funtions [71]. If it contributes to the maintanence of healthy 
tissues and organs it is considered to be a food ingredient [71, 218]. Sometimes 
the difference is vague and similar preparations can be sold under the food 
and drug laws [71]. When evaluating the health effects of foods, less dramatic 
effects that develop during a longer period compared to those induced by 
drugs can be expected. Allergic reactions and food intolerances excluded, 
serious side effects caused by foods are rare. The physiological effects of foods 
are commonly mediated via the activity of several compounds.           
In the literature review of this thesis the health effects of sea buckthorn berries 
and oil are reviewed and an introduction to the sea buckthorn components 
potentially beneficial for humans is presented. This work covers only the 
publications available in English. A review including articles in Chinese and 
Russian, concerning the health effects of lipophilic sea buckthorn compounds 
has been written by Yang in 2001 [230]. Only sea buckthorn berry and 
berry/seed oils are discussed in this thesis, whereas the literature concerning 




The original research presented in this thesis comprises two clinical trials of 
randomized, double-blind, placebo- controlled, parallel design. One focuses on 
the effects of whole sea buckthorn berries, and the other on the sea buckthorn 
oil. In the whole berry trial, the effects of sea buckthorn on the common cold 
and inflammation are of main interest. The common cold is a mild upper 
respiratory illness, which usually is of short duration, and cures without 
medical intervention. Due to the high incidence, however, it causes 
considerable costs and bacterial complications may occur. As the common cold 
is caused by numerous viruses that have varying pathogenetic mechanisms, 
there is no universal treatment or medical prevention for it [80].  
The oil trial focuses on dry eye. Dry eye is a common condition, reported to 
affect even up to over 30% of people aged 50 years or more [2, 159]. It causes 
symptoms of discomfort and is associated with ocular inflammation and 
hyperosmolarity of the tear film protecting the ocular surface. The two main 
types of dry eye, which often interlink and fortify each other, are the aqueous-
deficient and evaporative dry eye. In the aqueous-deficient form the lacrimal 
secretion of tears is reduced. In the evaporative dry eye the evaporation of the 
aqueous tear film from the ocular surface is excessive, which may be due to 
abnormalities in the outermost lipid layer of the tear film [1, 159]. In addition 
to their individual main focuses, both trials investigate the effects of sea 
buckthorn on the risk factors associated with cardiovascular diseases and type 
2 diabetes.  
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2 REVIEW OF THE LITERATURE 
2.1 COMPOUNDS OF SEA BUCKTHORN BERRIES ASSOCIATED WITH 
POTENTIAL HEALTH EFFECTS  
2.1.1 Flavonoids, phenolic acids and lignans 
Sea buckthorn berries are rich sources of flavonoids and phenolic acids: 
phenolic secondary metabolites of plants that participate in the defence against 
ultraviolet radiation, insects and pathogens. Accordingly, their synthesis is 
affected by these stimuli and they are generally enriched in the outer parts of 
fruits, berries and vegetables [122]. The main flavonoid classes in the sea 
buckthorn berries are flavonols and proanthocyanidins (condensed tannins), 
while smaller amounts of flavanols and phenolic acids are present [174] 
(Figure 1). Sea buckthorn does not contain anthocyanins typical for red and 
blue berries, and only very minor amounts of ellagitannins (hydrolysable 
tannins) have been detected [107]. Like most biological compounds, the type 
and amount of phenolics in sea buckthorn berry vary depending on the origin, 
year of harvest, ripeness, processing and storage [36, 59, 238].  
The most abundant sea buckthorn flavonols are isorhamnetin (3’-methyl 
quercetin) and quercetin, which are mostly present as their 3-glycosides or 3, 7-
diglycosides [174, 176, 238]. The presence of kaempferol in H. rhamnoides and 
other sea buckthorn species has been reported [36, 167], though it is not always 
detected [77, 118].  Myricetin is seldom found [118]. The most common sugar 
residue in the 7-position of the flavonol aglycone is rhamnose, whereas the 3-
substituent is most often glucose, rutinose or sophorose [174, 176, 238]. In the 
commercially most important subspecies H. rhamnoides ssp. sinensis, ssp. 
rhamnoides and ssp. mongolica, the total content of flavonol glycosides varies 
between the range of 27 - 130 mg/100 g of fresh berries [238]. The highest levels 
were found in a Finnish cultivar Raisa (H. rhamnoides spp. rhamnoides X H. 
rhamnoides spp. caucasica) and the lowest in a Russian cultivar Vitaminaya (H. 
rhamnoides spp. mongolica). Pressed and pasteurized juice of H. rhamnoides cv. 
Hergo had a flavonol glycoside content of 36 mg/100 ml, and additionally 
contained isorhamnetin aglycone at a level of 0.14 mg/100 ml. Use of 
pectinolytic enzymes in juice manufacturing did not affect the total content of 
flavonol glycosides, but reduced the amount of isorhamnetin aglycone [174]. 
Compared to other foodstuffs, the content of isorhamnetin, the main flavonol 
aglycone in most sea buckthorn subspecies, is exceptionally high in sea 
buckthorn berries [214]. Values of 17 - 66 mg isorhamnetin aglycone/100 g 
fresh weight have been reported by Määttä-Riihinen et al. [118, 167] and 
approximately 30 - 35 mg/100 g by Yang et al. [238].  In the berries most of the 
aglycone is present as glycosides. The only foods having an isorhamnetin 
content above 10 mg/100g in the U.S. Department of Agriculture Database are 
Review of the Literature 
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dill (44 mg/100 g) and dried parsley (331 mg/100 g) [214]. The levels of 
quercetin aglycones in the study of the main commercial subspecies by Yang et 
al. [238] are ≈ 5 - 10 mg/100 g, whereas others have reported contents of 6 - 17 
mg/100 g fresh weight [77, 118, 167]. In sea buckthorn and other natural 
sources, most of the quercetin aglycones are attached to sugar moieties. These 
values are higher compared to those found in most apple species, and 
comparable to the levels found in kale [214], both considered as good sources 
of quercetin. For onions, somewhat higher values of 7 - 33 mg/100 g are 
reported [214]. 
According to Rösch et al. sea buckthorn juice contains small amounts of 
catechin (1.9 - 2.6 mg/100 ml) and epicatechin (0.3 - 0.5 mg/100 ml) which 
belong to the flavanol group of flavonoids [174]. Considerably smaller 
concentrations have been reported as well [118]. The presence of monomeric 
(+)-gallocatechin and (-)-epigallocatechin in the pomace of cv. Hergo was 
reported by Rösch et al. [175].  
Proanthocyanidins (condensed tannins) consist of flavanol subunits. The ones 
consisting of only (epi)catechin subunits are called procyanidins, whereas 
those consisting of (epi)gallocatechins are called prodelphinidins. The subunits 
are commonly linked through a C4→C8 or C4→C6 bond (B type). In the A-
type proanthocyanidins there is an additional ether bond between C2→C7 
[177]. A-type proanthocyanidins are present in cranberry (and other Vaccinium 
species), and are suggested to be responsible for the protective effects of 
cranberry against urinary tract infections [87, 169]. According to Rösch et al. 
[177], the composition of proanthocyanidins in sea buckthorn pomace is 
exceptional because of the high proportion of prodelphinidins, as commonly in 
foodstuffs the proanthocyanidins are exclusively procyanidins or mixtures of 
both. Määttä-Riihinen et al. [118] found almost equal amounts of procyanidins 
and prodelphinidins in H. ramnoides berries.  
The amounts of proanthocyanidins reported for sea buckthorn vary greatly in 
the literature. This is partly because of differences in genetic background and 
processing. Differences in the analysis methods may affect this as well, and the 
analysis is often described as challenging [86, 118, 174]. In cv. Hergo the total 
amount of proanthocyanidins is comparable to that of flavonol glycosides: 35 - 
57 mg/100 ml juice [174]. Considerably higher (276 mg/100 g fresh weight) 
values were reported for berries grown in Canada (species undefined), and 
lower (0.1-1 mg/100 g fresh weight) for Finnish (H. rhamnoides) berries [86, 118].  
In general, fruits, berries, beans, certain cereals and nuts, as well as wine and 
beer are good sources of proanthycyanidins. Among the richest berry sources 
are blueberries (180 - 332 mg/100 g), cranberries (419 mg/100g), chokeberries 
(664 mg/100 g), black currants (148 mg/100 g) and strawberries (145 mg/100 g) 
[70].   
Proanthocyanidins together with ascorbic acid (in part due to its high 
concentration) account for the majority of the antioxidant activity of sea 
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buckthorn juice in vitro. Isorhamnetin and its major glycosides are not as good 
radical scavengers as the other flavonoids and phenolic acids in the juice [174]. 
However, in vitro trials suggest other potentially important effects [78]. 
Depending on the choice of analysis method higher antioxidativity of 
isorhamnetin compared to ascorbic acid has been reported as well [155]. 
Sea buckthorn juice contains low concentrations of phenolic acids: gallic acid 
0.15 – 0.26 mg/100 ml and protocatechuic acid 0.21 - 0.29 mg/100 ml (cv. Hergo) 
[174]. Also the presence of other hydroxybenzoic acid derivates, as well as 
hydroxycinnamic acids, has been indicated, several of them as esters or 
glycosides [9]. The amount of ellagitannins (hydrolysable tannins), rare in most 
foodstuffs but present in some berries, is low in sea buckthorn (1 mg/100 g 
fresh berries) [107].  
The total contents of lignans secoisolariresinol and matairesinol in the H. 
rhamnoides ssp. sinensis, ssp. rhamnoides and ssp. mongolica berries vary between 
8 to 139 μg/100 g fresh berries and 51 to 319 μg/100 g dry berries. These 
amounts are comparable to those reported for cloudberry, raspberry, black and 
red currant.  However, they are lower compared to the levels found in 
strawberry (Fragaria ananassa) and berries of the Vaccinium genus, where 
secoisolariciresinol contents of up to 1510 μg/100 g have been reported. 
Linseeds are among the richest sources and contain lignans up to 400 000 
μg/100 g of the dry mass [234]. 
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Figure 1. Main phenolic compounds of sea buckthorn berry  
In vitro studies suggest antioxidantive, anti-inflammatory, antimicrobial and 
anti-proliferative effects of flavonoids found in sea buckthorn berries [23, 61, 
78, 134, 166, 174]. Epidemiological data indicates that flavonoids may have 
beneficial effects on the risk and development of cardiovascular diseases, 
whereas the evidence concerning cancer is less consistent [11]. Intervention 
trials in humans indicate that quercetin may affect markers of carcinogenesis 
and antioxidant biomarkers in plasma. On the other hand, in several trials no 
effects were observed. The positive effects of proanthocyanidins and their 
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monomeric subunits, flavanols, in human interventions include increase of 
plasma antioxidant activity, decrease of platelet aggregation, reduction of 
plasma low-density lipoprotein (LDL) cholesterol level and a decrease in 
susceptibility to oxidation [224]. The human intestinal bacteria can convert 
plant lignans into the enterolignans enterolactone and enterodiol, which can 
act as the agonists or antagonists of estrogen. Conclusions from 
epiodemiologic studies concerning lignans are similar to those made for 
flavonoids: lignans seem to have beneficial effects on the risk factors of 
cardiovascular diseases, while the effects on cancer are more debatable [11]. 
The effects of flavonoids in vivo cannot be predicted easily based on their 
concentrations in foods or their effects observed in vitro. As reviewed by 
Manach et al. [122], this is affected by the efficiency and site of absorption, 
activity of the metabolites and rate of elimination. It is likely that most of the 
polyphenol glycosides are not hydrolyzed in the stomach. In the small 
intestine only aglycones and some glucosides are absorbed, flavonol 
glucosides even more efficiently than the aglycones. Flavonoids linked to 
rhamnose must reach the colon, where they are hydrolyzed by the microflora 
before being absorbed. Trimers or larger oligomers of proanthocyanidins are 
likely not degraded in the stomach or absorbed in the small intestine in their 
native form. Due to their poor efficiency of absorption they may affect the 
gastrointestinal tract locally. Alternatively, the effects are caused by the 
phenolic acids produced through degradation and metabolism of larger 
phenolic compounds by the intestinal microbes. Manach [122] points out that 
as most of the other antioxidants are absorbed before the colon, the local 
actions of flavonoids may be of special importance for the health of the 
gastrointestinal tract.  
After the absorption of flavonoids, three main types of conjugation take place: 
methylation (mainly in the liver and kidneys, but likely also in the intestine), 
sulfation (mainly in the liver) and glucuronidation (mainly in the enterocytes 
and liver) [122]. Lehtonen et al. [112] investigated the excretion and 
glucuronidation of sea buckthorn berry flavonols after ingestion of 300 g 
frozen berries as a breakfast. Post-prandially only glucuronides of 
isorhamnetin and kaempferol, but no flavonol glycosides or quercetin-
glucoronides were detected in the plasma. The flavonoid metabolites are 
excreted through the urinary or the biliary route [122]. After a sea buckthorn 
meal both isorhamnetin glucuronides and isorhamnetin-3-glucoside, and 
quercetin-3-glucoside and -glucuronide were present in urine. In feces, 
glycosides of isorhamnetin, quercetin and kaempferol were observed. The 
levels of flavonols in the plasma returned to the baseline levels by 8 h after the 
sea buckthorn berry meal [112]. 
In the blood the flavonoid metabolites are bound to plasma proteins, especially 
albumin. Even though flavonoids may protect LDL against oxidation, only a 
small fraction of them is associated with LDL in the blood, and the protective 
effect is thought to take place at the interphase of the lipophilic and 
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hydrophilic phases. Little is known about the accumulation of flavonoids in 
specific organs, but aortic endothelial cells and the brain have shown regional 
selectivity for certain flavonoids. In the organs further metabolism may take 
place, and the tissular metabolites may differ from the ones in the blood 
making the extrapolation of in vitro results to potential in vivo effects even 
more difficult [122].  
2.1.2 Vitamin C 
Sea buckthorn berry is among the richest food sources of vitamin C (Figure 2) 
[18], even though the genetic background, harvesting date [101, 167], growth 
conditions [208], storage and processing [75] greatly affect its concentrations 
and oxidation state. In general, the vitamin C content decreases during the 
ripening of the berries [101, 167]. Levels as high as 13 g/l of juice were reported 
in Chinese H. rhamnoides ssp. sinensis berries, and values around 10 g/l were 
found for several samples of this subspecies. As averages of several samples 
from different locations and harvesting times, the vitamin C contents of H. 
rhamoides ssp. sinensis, ssp. rhamoides and ssp. mongolica were 8.6, 1.7 and 0.5 g/l 
of berry juice, respectively [101]. In H. rhamnoides juice made of berries 
cultivated in Canada, average values of about 1.7 g vitamin C/l of juice were 
observed [18]. This resembles the concentrations found in Russian ssp. 
mongolica varieties grown in Finland (0.3- 1.3 g/l juice) [208], and in German H. 
rhamnoides cultivars (1.8-3.7 g/kg fresh berries) [167]. The vitamin C content in 
the ssp. sinensis berries is comparable to that reported for rose hip berries 
(roughly 12.5 g/kg), and several times higher than those in orange (roughly 0.5 
g/kg), apple (0.1 g/kg) and black currant (1.2 g/kg) [135].  
The physiological functions of vitamin C derive from its strong antioxidant 
activity and its action as an essential cofactor for several enzymes. It may 
regulate the expression of certain genes, affect the adhesion of monocytes to 
endothelium and the aggregation of platelets and leucocytes, among other 
functions [114]. Vitamin C supplementation may have beneficial effects on the 
common cold in certain subpopulations [81], and it is associated with lower 












Figure 2. Ascorbic acid and dehydroascobic acid 




Inositols (Figure 3) and their derivatives are essential messenger molecules in 
cells. myo-Inositol is present in cell membranes as phosphatidylinositols. 
Phosphatidylinositols can, due to extracellular stimuli, be enzymatically 
cleaved to form inositol phosphates and 1,2-diacylglycerol, both of which are 
involved in the intracellular signal transduction [97, 220]. Inositol 
hexaphosphate is a strong antioxidant and neurotransmitter. As reviewed by 
Vucenik et al. [220], inositol hexaphosphate and its less phosphorylated forms 
may have anti-cancer potential by affecting immune functions, inflammation, 
cell differentiation and apoptosis, among others. In plants, inositols are 
thought to act as cryoprotectants or regulators of osmotic stress, as their levels 
are increased under cold or dry conditions [100].  
The presence of (-)-2-O-methyl-L-chiro-inositol (L-quebrachitol), and trace 
amounts of chiro-inositol and myo-inositol in the sugar fraction of sea 
buckthorn berries have recently been reported by Yang [237] and Kallio et al. 
[100]. The amount of L-quebrachitol was highest in the ssp. sinensis, where 
mean concentration of 0.8 mg/100 ml of juice was observed. Concentrations of 
0.3 mg/100 ml and 0.2 mg/100 ml in the ssp. rhamnoides and ssp. mongolica 
juices, respectively, were observed [237]. Quebrachitol, having physiological 
effects similar to those with other inositols, had not been reported in edible 
fruits previously. Quebrachitol has antioxidant and free radical scavenging 
properties, which are likely to contribute the cytoprotective effects observed in 
vitro and in animals [47, 141]. In a mouse study concerning gastroprotection, 
the lowest doses tested (12.5 mg/kg and 25 mg/kg) were the most effective [47, 
141].  
 







              
Figure 3. myo-inositol and 2-O-methyl-L-chiro-inositol (L-quebrachitol) 
2.1.4 Berry and seed oils 
The proportion of seeds is approximately 4 - 9% of the fresh weight of sea 
buckthorn berries. The oil content of the seeds is reported to be approximately 
11% in ssp. rhamnoides, 13% in ssp. mongolica and 7 - 10% in ssp. sinensis [102, 
196, 236]. The proportion of oil in the soft part was 2.8% of fresh weight in ssp. 
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rhamnoides and 1.7% in ssp. sinensis [236]. In a whole fresh berry, including the 
seeds, the oil content was between 2.1 - 4.1% of fresh weight in ssp. sinensis, 
3.5% in ssp. rhamnoides and 5.9% in ssp. mongolica [102, 236].  
2.1.4.1 Triacylglycerols, glycerophospholipids and fatty acids 
Triacyglycerols form the main lipid class in the seed and the soft part oils, and 
comprise approximately 80% of the oil from whole berries of ssp. mongolica 
and ssp. sinensis [102]. The proportion of glycerophospholips in the oil from 
whole berries is approximately 3 - 6% [102]. According to a study by Kallio et 
al. [102], the proportions of lipid classes in seed oil clearly differ between 
subspecies. The proportion of triacylglycerols varied from 86% in ssp. sinensis 
to 66% in ssp. mongolica, whereas glycerophospholipids comprised 
approximately 10 and 8% of the seed oils in ssp. sinensis and ssp. mongolica, 
respectively [102].  
The fatty acids of the seed and soft part oil differ greatly. Due to the 
dominance of the pulp and peels in a whole berry, the composition of the oil 
from the whole berry resembles that of the soft part oil. Main fatty acids in the 
oil from the soft parts of the berry are palmitoleic (27 - 33%), palmitic (27 - 
28%), oleic (17%), linoleic (9 - 13%), vaccenic (8 - 9%) and α-linolenic (3 - 7%) 
acids  ([102, 196, 236], numerical values for ssp. rhamnoides and ssp. sinensis, 
according to the report by Yang & Kallio [236]). In the seed oils of all the tree 
major commercial subspecies the main fatty acids quite regularly are linoleic 
(39 - 41%), α-linolenic (27 - 31%), oleic (17 - 19%), palmitic (7 - 9%), stearic (3%) 
and vaccenic acids (2 - 3%).  
In humans, α-linolenic and linoleic acids are precursors of other long-chain n-3 
and n-6 fatty acids. They in turn are precursors for eicosanoids and other local 
hormones modulating inflammation and secretory and cardiovascular 
functions. As a not always accurate generalization, the effects of n-6 derived 
eicosanoids are commonly described as pro-inflammatory, whereas the effects 
of n-3 derived eicosanoids are considered antiinflammatory or neutral [31, 32, 
97, 188]. Conversions of the 18-carbon n-3/n-6 fatty acids to their derivates of 
longer chains and a higher degree of unsaturation involve a series of 
desaturaturases and elongases shared by the n-3 and n-6-families (Figure 4). 
Competition between the fatty acids of n-3 and n-6 families for the same 
enzymes in these conversions makes the n-3/n-6 ratio in the diet important [31, 
32, 97, 188]. Additionally, the n-3 fatty acids may also affect the expression of 
inflammatory genes and cytokine production [31, 32].  
Western diets commonly contain n-6 and n-3 fatty acids in the ratio of 10:1 or 
higher, which is undesirably high according to most authorities. The current 
recommendations for the n-6/n-3 ratio in the diet vary from less than 4:1 to 10:1 
[97]. Sea buckthorn seed and berry oils are considered to be of particular 
nutritional interest because their n-6/n-3 ratio of <2:1 is low, compared to most 
other vegetable oils [51].  
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Recently, the role of fatty acid amides (endocannabinoids) in modulating 
inflammation has been extensively studied. This group of endogenous 
signalling lipids involves both saturated and unsaturated fatty acids, among 
them palmitic acid in N-palmitoyl ethanolamide (PAE), and oleic acid in 
oleoylethanolamide (OEA). PAE has anti-inflammatory effects via mechanisms 
that are not completely known so far. The inhibiting effect on cyclo-oxygenase-
2 (COX-2) and inducible nitric oxide synthase (iNOS) expression have been 
suggested [162]. 
























































































Figure 4. Synthesis of long-chain n-3 and n-6 fatty acids from α-linolenic and linoleic 
acids, respectively, and a simplified overview of the messangers derived from them in 
humans. Modified from [188] and [178]. COX = cyclo-oxygenase, LOX = lipoxygenase 
2.1.4.2 Vitamin E 
Vitamin E is a collective name for tocopherols (having a saturated phytol side 
chain attached to the chromanol structure) and tocotrienols (having an 
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unsaturated side chain) [211]. Both sea buckthorn berry and seed oils contain 
tocopherols and tocotrienols, the amounts and proportions of which are 
dependent on the genetic origin, growth conditions and ripeness of the berries 
[6, 101, 102, 196]. The seeds of H. rhamnoides ssp. mongolica (average 250 mg 
tocols/ kg seeds) and ssp. rhamnoides (290 mg/kg) seem to be better sources of 
tocopherols and tocotrienols, compared to those of spp. sinensis (130 mg/kg). 
The major forms of vitamin E in the seeds are -and -tocopherols [101, 196] 
(Figure 5), which represent typically 40 - 50% and 20 - 40%, respectively, of the 
total contents of tocols [101]. γ-Tocotrienol was the only tocotrienol detected in 
the choloform-methanol extracted sea buckthorn seed oils by St George & 
Cenkowski [196], whereas Kallio et al. [101] report the presence of β-
tocotrienol in seed oils. According to Kallio et al. [101] the tocopherol and 
tocotrienol contents of chloroform-methanol-extracted seed oil is typically 100 - 
300 mg/100 g in ssp. rhamnoides and ssp. sinensis from various growth 
conditions and harvest times, in accordance with the levels reported for ssp. 
sinensis seeds from a Canadian harvest (220 - 260 mg/100 g oil) by St George & 



























Figure 5. Main tocopherols of sea buckthorn seed oil and an example of seed oil 
tocotrienols found in smaller amounts 
When the berries were compared in the study by Kallio et al. [101], the spp. 
sinensis was clearly the best source of vitamin E. Average concentrations of 
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tocols in samples from several locations were: ssp. sinensis 120 mg/kg fresh 
berries, spp. rhamnoides 40 mg/kg berries, and ssp. mongolica 50 mg/kg berries. 
-Tocopherol was the main form representing 70 - 80% of the total tocopherols 
and tocotrienols. The berry oil extracted by chloroform-methanol from ssp. 
sinensis contained typically 400 - 700 mg tocopherols and tocotrienols/100 g, 
whereas the tocol content in ssp. rhamnoides and ssp. mongolica oils was 100 - 
200 mg/100g. Somewhat lower values were reported by St George & 
Cenkowski [196] for the ssp. sinensis berries grown in Canada (340 - 490 
mg/100 g oil, mainly -tocopherol). In the Canadian study, the oils for the tocol 
analyses were extracted using chloroform-methanol [196]. Both Kallio et al. 
[101] and St George & Cenkowski [196] specify β-tocotrienol as the major 
tocotrienol in the soft part of the ssp. sinensis berries. In ssp. rhamnoides and 
ssp. mongolica the main tocotrienol is γ-tocotrienol [101]. Due to the 
distribution of oil between the seeds and soft part of the sea buckthorn berry, 
the proportion of tocopherols and tocotrienos originating from the seeds and 
the soft part varied between 3 - 13% to 77 - 97%, respectively [101]. 
In dietary reference values and recommendations, -tocopherol is the only 
tocol included in the definition of vitamin E [55, 211], and it is not 
recommended to include other forms by using conversion factors [211]. In the 
case of synthetic -tocopherol, a conversion has to be made to compensate for 
the stereochemical differences from the natural form [211]. Also the food 
composition databases commonly state 1 mg vitamin E as equating 1 mg of -
tocopherol [135]. Sea buckthorn berries of the ssp. sinensis especially can be 
considered as a good source of vitamin E. The -tocopherol contents in the ssp. 
sinensis berry samples with the highest concentrations [101] are comparable to 
the levels in hazel nuts (15 mg/100 g) and rapeseed oil (19 mg/100 g), 
commonly considered as good sources [135].  
Antioxidant activity is the major function of vitamin E in the body. It is 
transported in the plasma lipoproteins and is found in membranes and organs 
rich in lipids, where it protects the unsaturated fatty acids from oxidation 
[211]. -Tocopherol has been described to participate in the regulation of cell 
proliferation of the vascular smooth muscle cells, regulation of protein kinase 
C and the inhibition of phospholipase A2. Epidemiological studies and some, 
but not all, of the interventions suggest positive effects of -tocopherol on 
degenerative diseases such as cardiovascular diseases, Alzheimer’s disease and 
cancer [211].  Conflicting effects on infection risk have been observed [82, 83, 
84, 125]. Even though not included in the nutritional definition of vitamin E, 
and not as effective an antioxidant as α-tocopherol, other tocopherols may be 
beneficial as well [211]. -Tocopherol has a stronger anti-inflammatory effect 
compared to -tocopherol in vitro. It inhibites COX-2 activity in macrophages 
and human epithelial cells and reduces the expression of iNOS in 
macrophages, whereas the -tocopherol is ineffective or less effective [94].  
Even if the amounts of tocotrienols in sea buckthorn oils are smaller compared 
to those of tocopherols, they may have specific physiological effects, as 
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reviewed recently by Colombo [42]. Tocotrienols have been observed to inhibit 
cholesterol biosynthesis in animal cells by suppressing the enzymes involved. 
Indications of lowering effects on blood cholesterol in humans have been 
reported. Tocotrienols have in vitro antiproliferative and apoptotic activities in 
normal and cancer cells. α-Tocotrienol has been reported to demonstrate 
preventive effects against neurodegeneration. This has not been observed with 
α-tocopherol [42]. 
2.1.4.3 Carotenoids 
The sea buckthorn pulp oil is especially rich in carotenoids (Figure 6), which 
give the berry its orange color. In general, the concentrations of carotenoids 
increase during ripening [5, 167, 196], but the effect of the genetic origin seems 
to be even stronger than that of the harvest year or time [5]. The total 
carotenoids in the pulp and seed oils of H. rhamnoides ssp. sinensis berries 
cultivated in Canada varied between 489 - 818 mg/100 g and 24 - 28 mg/ 100 g, 
respectively (lipids extracted using chloroform-methanol) [196]. Somewhat 
lower levels of 69 - 342 mg/100 g oil were reported for H. rhamnoides, H. 
salicifolia and H. tibetana berry oils collected from the Himalayas (lipids 
extracted using chloroform-methanol) [168]. According to Raffo et al. [167] 
zeaxanthin, -carotene and -cryptoxanthin are the main  carotenoids in the 
three H. rhamnoides cultivars studied, where they were found at quantities of 5 
- 17 mg/100 g fresh weight of berries (lipid extraction of carotenoid analyses 
using tetrahydrofuran-methanol and petroleum ether). Zeaxanthin was the 
main carotenoid in cultivars Askola and Hergo (82 - 91% of total), whereas in 
Leikora the proportions of zeaxanthin (49 - 57%) and -carotene (33-39%) were 
more close to each other. The main carotenoids repoted in the three H. 
rhamnoides cultivars analysed by Andersson et al. [5] were zeaxanthin, -
carotene, -cryptoxanthin, lutein, lycopene, and -carotene (1.5 - 18.5 mg/100 g 
fresh weight, lipid extraction using ethanol-hexane). 




























Figure 6. Main carotenoids of sea buckthorn berries 
Sea buckthorn berries and oils are rich sources of carotenoids. According to 
rough estimates in the database of the National Institute for Health and 
Welfare, among the best food sources are rose hip berries (11 mg/100 g), 
watermelon (5 mg/100 g), carrots (11 mg/100g), sweet potato (9 mg/100 g) and 
sweet red pepper (6 mg/100g) [135]. For a carotenoid to have a provitamin A 
activity it must have at least one nonoxygenated -ionone ring. Therefore, of 
the major carotenoids in sea buckthorn, zeaxanthin, lutein and lycopene are 
not precursors of vitamin A, instead they have other potential mechanisms of 
effect. For carotenoids, there is currently no recommended daily intake. The 
recommended dietary allowances of vitamin A are expressed as retinol activity 
equivalent (RAE), where 1 g RAE = 12 g all-trans -carotene from foods or 2 
g all-trans -carotene from supplements (oil supplements, a highly absorbable 
form) [180].  
Epidemiological studies suggest that fruits and vegetables may be beneficial 
for reducing the risk of cardiovascular diseases and cancer. However, as 
reviewed by Ross [180], the evidence for the effects of certain individual 
components, including carotenoids is less consistent. In smokers and asbestos 
workers, supplementation with -carotene showed even a negative effect on 
the cancer incidence, though, unlike vitamin A, carotenoids even at high doses 
are not considered toxic as such [180]. Both pro- and nonvitamin A carotenoids 
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have modulatory effects on inflammation and immune fuctions in vitro, and 
may protect against age related macular degeneration [180, 183]. Carotenoids 
are important as antioxidants. As inflammatory reactions produce oxidant 
molecules, including nitric oxide (NO), peroxide and peroxynitrite, antioxidant 
action may be one of the mechanisms involved in the immunomodulation by 
carotenoids [180]. Intake of -carotene seems to be negatively associated with 
the inflammatory marker C-reactive protein (CRP) in middle-aged and older 
women [221]. β-Carotene is successfully used for the treatment of certain 
photosensitivity disorders, and the positive effects of vitamin A (systemic and 
topical) on the treatment of skin disorders like cystic acne and psoriasis are 
well known [180].  
2.1.4.4 Phytosterols 
The total sterol content of the H. rhamnoides ssp. rhamnoides and spp. sinensis 
seed oils was reported by Yang et al. [233] to be 1.2 - 2.3%. Total sterol content 
in the oils from the soft part of the ssp. rhamnoides and sinensis berries varied 
between 1.0 - 2.9%. Sitosterol constituted approximately 60 – 80 % of the sterols 
in all the oils extracted using chloroform-methanol [233]. St. George & 
Cenkowski [196] used the same method as Yang et al. [233] to analyse sterols 
in the seeds and berries of H. rhamnoides ssp. sinensis cultivated in Canada. A 
total content of 0.7 – 1.0% and 0.5 – 0.7% sterols in the berry and seed oils, 
respectively was found. The main sterol was always β-sitosterol (Figure 7).  
Phytosterols and phytosterol esters have a serum cholesterol lowering effect, 
most likely because they can interfere with the absorption of cholesterol [108]. 
β-Sitosterol has anti-inflammatory effects in human aortic endothelial cells in 
vitro [117]. As discussed by Loizou et al. [117] it may also have a 











Figure 7. β-Sitosterol 
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2.2 THE EFFECTS OF SEA BUCKTHORN BERRIES AND OIL ON THE 
HEALTH 
2.2.1 Antioxidative and cytoprotective effects  
2.2.1.1 In vitro cytoprotection by antioxidant activity  
Oxidative or nitrosative stress, the imbalance in the equilibrium status between 
prooxidant/antioxidant systems in cells is considered to contribute to the 
pathogenesis of many human diseases including cancer, cardiovascular 
diseases, and rheumatic disorders, among others [24, 207]. Reactive radical 
oxygen (superoxide anion, O2-; hydroxyl radical, HO∙; peroxyl radical, ROO∙) 
and non-radical oxygen (hydrogen peroxide, H2O2; singlet oxygen 1O2) and 
nitrogen (NO) species are produced in normal cellular processes, such as 
mitochondrial electron transport systems and cell signalling [207]. An excess of 
reactive oxygen (ROS) or nitrogen (RNS) species damage nucleic acids, lipids, 
proteins and carbohydrates, and ultimately interfere with the normal functions 
of cells and tissues [24, 207].  
ROS are necessary for the microbicidal activity of immune cells and 
components of the signalling generated by cytokines. The activation of 
phagocytes by proinflammatory mediators or bacteria leads to the production 
of large quantities of superoxide anion radical [24, 207]. There is a delicate 
balance between the immune system and ROS. Even though immune cells 
produce significant amounts of ROS, they have a high proportion of 
polyunsaturated fatty acids in their cell membranes and therefore are 
especially sensitive to external ROS [24].  
Cells have efficient enzymatic (superoxide dismutase, SOD; glutathione 
peroxidase, GPx; catalase) and nonenzymatic (glutathione, GSH; vitamin E in 
cell membranes) protective antioxidative mechanisms [24, 207]. In plasma, the 
concentrations of the above mentioned compounds are lower, and the role of 
vitamin C and proteins in antioxidative defence is considered to be more 
important [207]. In LDL, the oxidised form of which is considered highly 
atherogenic, the primary antioxidant is vitamin E [207]. Diet is important in 
providing the antioxidant components to the body [207]. Several sea buckthorn 
berry and oil components have antioxidant activity by their ability to scavenge 
free radicals, donate electrons and/or chelate metal ions catalyzing oxidation 
reactions. 
Many chemicals including nicotine, heavy metals and other pollutants have 
detrimental effects on cells and tissues by inducing the generation of reactive 
oxygen species and increased oxidative/nitrosative stress [199, 225, 228]. Also 
the cytotoxic effects of ionizing radiation and hypoxia are thought to be largely 
mediated by free radicals and oxidative damage [193]. The effects of sea 
buckthorn berry fractions and oil against cytotoxicity by oxidizing chemicals, 
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ionizing radiation, pollutants and heavy metals have been investigated in 
several in vitro (Table 1) and animal studies (Table 2).  
The in vitro studies have mostly concerned cells of the immune system and 
have been carried out using ethanol/alcohol extracts of H. rhamnoides berries. 
Even if most studies do not report the chemical composition of the preparation 
used, the alcohol extracts are likely enriched with flavonoids, sugars and acids. 
Sea buckthorn in vitro trials indicate cytoprotective activity against chemicals 
and radiation due to the increased antioxidant protection of the cells (Table 1). 
The reviewed studies included control groups and report using statistical 
methods, even if for some individual assays results of the statisctis were not 
always presented.  
Geetha et al. [63] investigated the effects of ethanol extract of sea buckthorn 
berries against nitrosative stress induced by sodium nitroprusside (SNP) in 
murine macrophages. SNP dissolves to water and realeases NO, which in the 
presence of superoxides forms higly reactive peroxynitrite radical. SNP at a 
concentration of 500 μg/ml generated NO at levels that were cytotoxic to the 
cells (decreased viability), increased the concentrations of reactive oxygen 
species, decreased the levels of intracellular antioxidants, induced 
mitochondrial and nuclear damage, and reduced phagocytosis by the 
macrophages. The addition of sea buckthorn berry extract to a level of 500 
μg/ml medium significantly reduced all of the above mentioned negative 
effects of SNP. Compared to the sea buckthorn leaf extract, the berry extract 
was found to be more effective in protecting against SNP-induced cytotoxicity. 
The authors suggest this may be due to a greater proportion of lipid soluble 
antioxidants in the berry extract. However, the compositions of the extracts 
were not presented. Both fruits and leaves were extracted using Soxhlet 
extraction, which due to its long duration and high temperature may cause the 
loss of bioactive compounds. The berries used as a raw material in the 
extraction were of the species H. rhamnoides, collected from the Himalayas.  
Recently, Geetha’s group [62] investigated the effects of sea buckthorn berry 
pulp flavonoids against tert-butyl hydroperoxide (t-BOOH)-induced 
cytotoxicity in rat lymphocytes. t-BOOH is an organic hydroperoxide pro-
oxidant that in the presence of Fe2+ generates butoxyl radicals. A commercial 
sea buckthorn flavonoid preparation, the detailed composition of which was 
not presented, was used. As in the group’s previous study with macrophages 
[63], the increased oxidative stress lead to reduced cell viability, increased 
production of free radicals, increased lipid peroxidation, DNA strand breaks 
and apoptosis. The flavonol preparation at level of 100 μg/ml medium 
significantly restricted all of the above mentioned effects of t-BOOH. A 
negative control was included, and the effects of individual antioxidants 
vitamin C, vitamin E, iron chelator deferoxamine (DFO) and butylated 
hydroxytoluene (BHT) were investigated as well. Compared to the individual 
compounds, the sea buckthorn flavonoids demonstrated a wider spectrum of 
protective effects. The protective effect of vitamin E and BHT against 
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cytotoxicity and free radical production was only small or nonexistent, 
whereas sea buckthorn flanoids, vitamin C and DFO all had marked effects. 
DFO, vitamin C and BHT did not protect against the lipid peroxidation effect, 
which was restricted by sea buckthorn flavonoids and vitamin E.  
Kumar et al. [109] investigated the effects of a sea buckthorn berry alcoholic 
extract named RH-3 against ionizing radiation and t-BOOH in mice and calf 
thymocytes. Gamma-radiation used in the study generates reactive oxygen 
species. It can also directly cause the degradation of cellular macromolecules, 
including DNA. Berries for the RH-3 extract were of the H. rhamnoides species 
collected from the Himalayas. Although UV-Vis spectroscopic and high 
performance liquid chromatographic (HPLC) profiles of the extract were 
presented, the compounds were not identified or quantified. In isolated 
thymocytes both gamma-radiation and t-BOOH treatment caused strand 
breaks of DNA, which was restricted in a dose dependent manner by RH-3 
preparation. The optimal doses in preventing the DNA strand breaks were 100 
- 120 g of RH-3/ml medium. At doses  150 g/ml pre- or post- irradiation, 
RH-3 induced an appreciable increase in the compaction of the chromatin. This 
was associated with less strand breaks of DNA and greater resistance to 
gamma-radiation. At lower concentrations of <100 g RH-3/ml medium the 
compaction was reversible, whereas high concentrations of  150 g/ml 
induced irreversible compaction (concentration of 120 g/ml not studied for 
reversibility of the compaction) [109].  
In vivo, it is likely that the RH-3 concentrations would be lower and irreversible 
compaction may not take place. As reviewed by Kumar [109], histones and 
some other agents like polyamine, may protect DNA from strand breaks by 
modulating the chromatin organization. Though reversible condensation may 
be radioprotective, irreversible condensation may lead to cell death in vivo. 
However, as such, without radiation treatment no effects of RH-3 on the cell 
viability were observed at concentrations from 20 to 200 g/ml. A mild free 
radical scavenging activity of RH-3 was observed. The authors suggest that in 
vivo, sea buckthorn flavonoids may affect chromatin organization and protect 
the cells against oxidative stress, and by both mechanisms protect tissues 
against radiation [109]. Throughout the study, a control group was included in 
the assays, but results of the statistical analyses were not always presented. 
Both pre- and post-radiation effects of RH-3 were investigated. However, it 
was not always clear for the reader which results concerned the post- and 
which the pre-radiation studies.     
Also Shukla et al. [193] report on the radioprotective effects of ethanol extract 
of sea buckthorn berries in murine thymocytes. H. rhamnoides berries from the 
Himalayas were used for manufacturing the extract named REC-1001. The 
total polyphenol content of REC-1001 was 68% w/w. Kaempferol, isorhamnetin 
and quercetin were identified but not quantified. REC-1001 concentrations 
from 10 g/ml to up to 500 g/ml median were used in the experiments of this 
study. REC-1001 decreased the radiation-induced DNA damage in all the 
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assays used to evaluate this. The highest concentrations (250 - 500 g/ml 
mediun) gave the best protective effects. REC-1001 also dose-dependently 
scavenged the hydroxyl radicals induced by radiation, scavenged chemically 
induced superoxide anions and reduced Fe3+ to Fe2+. It also totally stabilized 
the generation of 1,1-diphenyl-2-picryl hydrazyl (DPPH) radicals already at 25 
g/ml, which was the lowest concentration of REC-1001 tested. The authors 
suggest that antioxidant activity is focal in the radioprotection by REC-1001.  
Agrawala & Adhikari [3] investigated the effects of RH-3 against radiation 
induced cytotoxicity in human U87 cancer cells. RH-3 concentrations from 2.5 
to 10 g/ml medium were used in the assays. The chemical composition of the 
preparation was not defined but the extract was reported to be standardized. 
RH-3 alone without radiation did not affect the metabolic activity of U87 cells, 
suggesting it was nontoxic at these concentrations. The greatest effect against 
the loss of cell viability due to ionizing radiation was observed when the sea 
buckthorn extract was added to the medium 15 min before the radiation at 
concentrations of 7.5 and 10 g/ml medium. At concentrations of 5 - 7.5 g/ml, 
pretreatment of the medium with RH-3 restricted the increase of cellular and 
mitochondrial (7.5 g/ml) free radicals after radiation. However, at the level of 
10 g/ml, an increase in mitochondrial free radicals was observed. 
Pretreatment with the extract at concentrations of 5 g/ml medium or higher 
was efficient in preventing the apoptotic effects of radiation. The authors 
conclude that the antioxidant action of RH-3 prevents cellular and 
mitochondrial free radical production, which likely contributes to its ability to 
inhibit cytotoxicity and apoptosis induced by radiation.  
2.2.1.2 Animal studies on cytoprotection and antioxidant action   
Animal studies focusing on the protective effects of sea buckthorn via 
antioxidant mechanisms have concerned the effects of water and ethanol 
extracts, juice and seed oil (Table 2). As was the case for the in vitro studies, 
information concerning the composition of the fraction used is most often not 
comprehensive.  All studies report positive findings, but in some cases the 
doses used for the effect are fairly high. The dose of 500 mg of dried sea 
buckthorn extract/kg body weight/day used in the arsenic prevention studies 
by Gupta et al. [73, 74] would mean a dose of 30 g/ day for a person weighing 
60 kg.    
Mice studies by Goel et al. [65, 66] support the indications of radioprotection 
by sea buckthorn observed in vitro. The ethanol extract coded as RH-3 was 
used in both trials of Goel’s group. An HPLC chromatogram of the flavonoids 
in RH-3 is presented, but the compounds were not identified or quantified in 
the articles. In the first study [65], the number of mice was 56 or less depending 
on the effects investigated. Untreated controls were included but results of 
statistical analyses were not presented for all assays. A dose of 30 mg RH-3/kg 
body weight admistered 30 minutes before lethal gamma-irradiation had the 
greatest enhancing effect on the survival rate of mice 30 days post-radiation. In 
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the 30 mg/kg group 82% of the mice survived, whereas in the negative control 
group all the mice were killed. RH-3 had a protective effect against changes in 
hematological parameters induced by the radiation, and it showed in vitro 
antioxidant activity by several mechanisms [65]. 
In the second study by Goel et al. [66], 12 mice per assay were included and 
statistical comparisons between the treatment and control groups were 
presented. RH-3 was admistered intraperitoneally 30 minutes before radiation. 
It was not clear from the article which were the doses used for the experiments. 
However, RH-3 was reported to increase the number of surviving crypts in the 
jejunum, and reduce the number of apoptotic bodies in the crypts. The 
gastrointestinal tract is extremely sensitive to radiation, and the crypts are 
essential for the renewal of the intestinal epithelium.  
High level of arsenic in the drinking water is a problem in some developing 
countries. The intake of contaminated water may cause cancer, and skin and 
vascular lesions. Chronic exposure by different routes has also been associated 
with diabetes, hypertension, and atherosclerosis. The detrimental effects are 
thought to be mediated by increased oxidative stress induced by arsenic [73, 
74]. Gupta et al. [73, 74] investigated the effects of three water and ethanol 
extracts of sea buckthorn berry against arsenic toxicity in mice in two studies. 
In both they used the fruits of H. rhamnoides from the Himalayas. The 
extraction methods were described, but the chemical compositions of the 
products were not analyzed.  
In the first trial, 20 mice were exposed to arsenic in the drinking water for three 
months [74]. After that, the mice were orally given water or ethanol extracts of 
sea buckthorn for 10 days, or they did not receive any treatment. Additionally, 
five mice were treated as a control group, which received neither arsenic nor 
sea buckthorn during the course of the whole trial. The dose of the sea 
buckthorn extracts was 500 mg/kg body weight per day. After three months 
and ten days, the mice were killed and the effects of the arsenic and sea 
buckthorn were evaluated by analyzing biochemical markers from the blood 
and tissues.  
In the second trial [73] of 25 animals, the mice were orally given the sea 
buckthorn extracts at a dose of 500 mg/kg body weight/ day for two weeks 
before and during the three week arsenic exposure. Control groups getting no 
arsenic or sea buckthorn, and getting arsenic only, were included. After the 
treatments, the animals were sacrificed and blood and tissue samples were 
collected. The studies indicate the protective effects of sea buckthorn against 
arsenic induced oxidative stress, disturbances in hematological variables, heam 
synthesis and liver functions. Only minor changes in the tissue concentrations 
of arsenic were observed. The authors conclude that the protective effect of sea 
buckthorn is likely not due to the chelation of arsenic, but rather because of 
protection against oxidative damage. The water extract prepared under room 
temperature was the most effective in both of Gupta’s studies.       
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As opposed to the arsenic studies, the protection against lead induced 
neurotoxicity by sea buckthorn juice in mice was suggested to result from the 
juice chelating the heavy metal [228]. Antioxidant activity was observed as 
well. Xu et al. [228] admistered sea buckthorn berry juice to mice orally via a 
stomach tube before and during exposure to lead for 25 days. The 20% or 40% 
juice was given at a dose of 1 or 0.1 ml/10 g body weight/ day. A total of 50 
mice, including the control group, were included in the study. The H. 
rhamnoides berries for the juice were collected from the Huchun area of Jilin 
province in China, but the composition information of the juice was not 
provided. The sea buckthorn juice protected the mice against the lead acetate 
induced impairment in cognitive functions, rise of biomarkers of oxidation and 
decrease of several neurotransmitters. The effects of 40% juice were wider 
compared to those of the 20% juice.  
Cerebral edema is a serious complication of injuries in the central nervous 
system, including stroke, high-altitude illness and head injury. All of these 
conditions are associated with tissue hypoxia, which in turn is suggested to 
induce vascular leakage in the brain leading to edema [164]. Superoxide 
generation can be increased in response to both high and low levels of oxygen 
in vivo, and in spite of the seeming contradiction, hypoxia induces the 
generation of reactive oxygen and nitrogen species [123, 164]. These in turn 
may affect the vascular permeability under hypoxia.  
Purushothaman et al. [164] investigated the effects of sea buckthorn seed oil on 
hypobaric hypoxia in rats. Up to 56 rats, depending on the experiment, were 
included. CO2-extracted seed oil from Himalayan origin H. rhamnoides berries 
was used. The chemical composition of the particular oil used in this study 
was not analysed, instead the compositional information based on literature 
was presented. Initially doses of 1.5 to 5 ml/kg body weight were admistered 
orally using gastric canula 12 h before exposure to hypobaric hypoxia. The 
dose of 2.5 ml/kg was found to be most effective and used in most 
experiments. Pretreatment with sea buckthorn oil protected the rats against 
hypoxia induced transvascular leakage in the brain. It restricted the rise in 
biomarkers of oxidation and free radicals and improved the hypoxic 
tolearance. Both positive and negative control groups were included in this 
study.    
Sulfur dioxide (SO2) is an air pollutant that is absorbed through the respiratory 
tract and distributed to tissues, where it can induce oxidative stress [181, 225]. 
Two mice studies by Ruan et al. [181] (a total of 84 animals) and Wu et al. [225] 
(60 mice), suggest that the intake of sea buckthorn seed oil may protect against 
the negative effects of SO2. Ruan et al. used CO2-extracted seed oil from wild 
Chinese H. rhamoides berries and reported the vitamin E and carotenoid 
content of the oil. Wu et al. did not report the method of oil extraction, 
chemical composition of the oil or the origin of the berries.  
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Ruan et al. [181] intraperitoneally injected the mice with 2 - 8 ml of oil/kg body 
weight for three days before SO2 inhalation for five days. It was not clearly 
specified in the article whether the sea buckthorn admistration was continued 
during the SO2 inhalation. Wu et al. [225] used the same range of doses. They 
started the treatment three days before the SO2 inhalation for seven days. The 
oil was given to the mouse throughout the study. Ruan et al. [181] report a 
modest protective effect of sea buckthorn seed oil against SO2 induced changes 
in organ/body ratio and chromosome damage in bone marrow. Wu et al. [225] 
found that sea buckthorn seed oil prevented the SO2 induced increase in the 
oxidation marker thiobarbituric acid reactive substances (TBARS) in the lungs 
and protected against SO2 induced changes in the glutathione activities in the 
lungs.  
Süleyman et al. [199] studied the effects of combined sea buckthorn juice and 
hexane extract against nicotine induced oxidative stress in rats. The extract was 
prepared from Turkish H. rhamnoides berries, and admistered to the rats orally 
by a stomach tube at 1 ml/kg body weight/ day for three weeks. The chemical 
composition of the berry preparation was not reported. A total of 32 rats were 
included to the four groups getting only nicotine, nicotine and sea buckthorn, 
nicotine and vitamin E, and a control group getting neither nicotine nor sea 
buckthorn for three weeks. Statistical analyses were performed. Sea buckthorn 
extract restricted the nicotine induced decrease in blood antioxidants and rise 
in biomarkers of oxidation. Contrary to vitamin E, sea buckthorn also 
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2.2.2 Inflammation and immunomodulation 
Oxidation reactions are involved in inflammation. Antioxidants are important 
in protecting cells of the immune system and modulating inflammation [15, 24] 
(Tables 1 and 2). A few studies especially aimed at investigating the effects of 
sea buckthorn berry fractions on inflammation and immunity have been 
carried out (Table 3). Outside the scope of this review, several articles have 
been published concerning the immunomodulative effects of sea buckthorn 
leaves.  
Depending on the situation, either boosting or inhibiting the immune response 
is desirable. The anti-inflammatory effects of flavonoids and other food 
components are considered beneficial, as chronic low grade inflammation 
contributes to the pathogenesis of cardiovascular diseases, asthma and 
rheumatoid arthritis, among others [15, 154]. However, for the defence against 
microbial infections, potent inflammatory reactions and a competent immune 
system are essential, and excess suppression of inflammation is undesirable 
[195].  
The immunomodulation studies have focused on effects of sea buckthorn 
flavonoids and flavonoid rich fractions. Both stimulation [128] and attenuation 
[23, 89] of inflammation has been reported depending on the study design and 
target cells. All studies included control group(s), and the results were 
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An in vitro study by Geetha et al. [64] concerning the ethanol extracts of sea 
buckthorn suggests positive effects in immune cells exposed to oxidative 
stress. The study was carried out using the ethanol extracts of leaves and 
berries of H. rhamnoides collected from the Indian Himalayas. The chemical 
composition of the extracts was not presented. At a dose of 500 μg/ml medium 
the leaf and berry extracts inhibited the chromium(IV) induced production of 
free radicals, apoptosis, fragmentation of DNA and drop of antioxidant status 
in rat lymphocytes. Both sea buckthorn fractions restricted the inhibition of 
lymphocyte proliferation caused by chromium(IV). The leaf extract had a 
stronger cytoprotective and antioxidative effect compared to the berry extract. 
The authors conclude that sea buckthorn extracts have immunomodulating 
activity, at least in part due to their antioxidativity.  
Dorhoi et al. [48] studied the effects of herbal extracts on cellular immunity in 
vitro using samples from laying hens. From the study report it was not totally 
clear whether berries or some other part of H. rhamnoides was used to gain the 
ethanol extract used. The compositions of the extracts were not presented. 
Concentrations of sea buckthorn extract from 50 – 600 μg/ml medium were 
used. Sea buckthorn extract at a concentration of 50 μg/ml medium enhanced 
the membrane functions of the hen magrophages. At doses of 200 - 400 μg/ml 
medium sea buckthorn increased the activity of circulating phagocytes, 
whereas with higher or lower doses the effect was opposing. At concentrations 
of 400 μg/ml medium, sea buckthorn also inhibited leukocyte proliferation in 
another experiment of the study. Even though the composition of the sea 
buckthorn extract was not analysed, the authors speculate on the role of 
vitamin C and antioxidant activity [48].  
Hu et al. [89] suggest the anti-inflammation and anti-senility effects of sea 
buckthorn berry oil via the modulation of cyclic adenosine mono phosphate 
(cAMP) production. cAMP is a second messenger that transmits signals from 
hormones and other extracellular transmitters in intracellular pathways, 
including those related to inflammation. cAMP’s effects are mediated by its 
effects on the activity of the cAMP-dependent protein kinase (PKA). The 
elevation of intracellular cAMP is associated with the inhibition of lymphocyte 
activation. Compounds that can induce cAMP elevation have been shown to 
be immunosuppressive and anti-inflammatory. cAMP is commonly reduced in 
ageing [89].  
Hu et al. [89] admistered sea buckthorn oil at doses of 0.72 - 4.5 g/kg body 
weight/ day to old rats for 180 days. Berry oil from Chinese sea buckthorn, 
extracted by crushing and centrifuging was used. The species of Hippophaë or 
details of the extraction method were not defined. The three main fatty acids of 
the oils were reported to be palmitic acid, palmitoleic acid and oleic acid. Sea 
buckthorn oil was found to raise the serum levels of cAMP and increase the 
cAMP concentration and PKA activity in the hepatic tissues of rats. The 
authors hypothesise this could contribute to the anti-inflammatory and anti-
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senility effects of sea buckthorn oil. For significant effects, a dose of 1.8 g sea 
buckthorn oil/kg body weight was required.   
Nuclear factor-B (NF-B) is a transcription factor that regulates the expression 
of several inflammatory genes [15]. In unstimulated cells it locates in the 
cytoplasm bound to IκBα and IκBβ proteins. When stimulation occurs, IB is 
phosphorylated by specific kinases, leading to degradation of IB by 
proteosomes. Consequently NF-B moves into nucleus, binds to promoter 
region of the target genes for inflammatory proteins (cytokines interleukin-6 (IL-
6) and tumor necrosis factor-α (TNF-) and adhesion molecules, among others), 
and induces their expression. NF-B is activated by several stimuli, including 
certain cytokines, oxidants, viruses, antigens and ultra violet-radiation [15].  
Mishra et al. [128] studied the in vitro immunomodulatory activity of sea 
buckthorn berry flavonoids in human and mouse cells. The flavonoids were 
obtained from a Chinese company but other information concerning the origin 
or processing of the berries was not reported. The total polyphenolic content of 
the preparation was 310 mg/ml as a gallic acid equivalent. Flavonoid 
concentrations from 100 to 500 μg/ml medium were used depending on the 
assay. At this concentration range no cytotoxic effects by the flavonoids were 
observed. The flavonoids, at a dose of 200 μg/ml medium, induced the 
activation of pro-inflammatory transcription factor NF-κB in human peripheral 
blood mononuclear cells (PBMC). At concentrations of 100 - 200 μg/ml 
medium, the flavonoids increased the production of IL-6 and TNF-α in 
stimulated (stimulation with lipopolysaccharide) and in nonstimulated PBMC. 
The sea buckthorn flavonoids did not affect the production of NO in the 
stimulated or nonstimulated mouse magrophages. The authors conclude that 
the activation of NF-κB target genes by sea buckthorn flavonoids may enhance 
immune responses and be beneficial against microbial infections.  
Boivin et al. [23] investigated the in vitro effects of 13 berry juices on 
inflammation and cell proliferation in human cancer cells. The sea buckthorn 
berry juice tested was prepared from H. rhamnoides cultivar Sunny, using a 
domestic juice extractor. The chemical composition of the sea buckthorn juice or 
other juices was not reported. Sea buckthorn juice at a concentration of 25 μg/ml 
medium was among the berry juices that significantly inhibited the TNF-
induced activativation of COX-2 expression, and the activation of NF-κB in 
human prostatic adenocarcinoma cells. Compared to most other juices, the anti-
inflammatory actitivity of sea buckthorn was strong. Only gooseberry (in two of 
the assays) and blackberry (in one of the assays) showed a stronger effect.  
Of the individual flavonols present in sea buckthorn, quercetin, kaempferol, and 
isorhamnetin inhibit the activation NF-B in activated macropahes in vitro [78]. 
As antioxidants have been shown to block the activation of kinases responsible 
for IB phosphorylation reactive oxygen species may be intermediary in this 
pathway. It is known that oxidative stress can fortify inflammation [15]. The 
reported opposing effects of the sea buckthorn on inflammation and NF-kB 
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emphasize the influence of the chosen fraction, dose, target cells or animals, and 
other methods of investigation on the outcome of the study.  
2.2.3 Proliferation, apoptosis and cancer 
Cancer is a consequence of genetic damage leading to unregulated 
proliferation and suppressed apoptosis of cells [147, 195]. The effects of sea 
buckthorn berry components on these processes have been investigated 
frequently in vitro, but less in vivo (Table 4). Both types of studies indicate the 
positive effects of sea buckthorn berry, and the flavonoid rich ethanol extract 
in particular. Several interrelated mechanisms are suggested and the 
possibility of the synergetic effects of the components is stressed.   
Although ethanol extracts and flavonoids are most often used as the test 
material in the cancer and tumorigenesis trials (Table 4), they may not be the 
most potent fractions. In human colon cancer cells in particular, the effect of 
the ethyl acetate fraction, rich in both ursolic acid and polyphenols, was more 
potent in inhibiting growth of cancer cells than the ethanol-water extract, 
richer in polyphenols and poorer in ursolic acid [69]. Ursolic acid (Figure 8) is a 
pentacyclic triterpene reported to have anticarcinogenic activity. Ursolic acid 
may inhibit the NF-B dependent gene expression and thus reduce 
inflammation [183], a mechanism observed for flavonoids as well.  
Carcinogenesis and chronic inflammation share common mechanisms. 
Inflammation-induced reactive oxygen and nitrogen species can damage DNA 
and other cellular components, and contribute to the formation of malignant 
cells [24, 110, 195]. Excessive expression or abnormal activity of 
proinflammatory contributors like iNOS, COX-2 [110, 195], proinflammatory 
cytokines and prostaglandins, can promote tumorigenesis by stimulating cell 
proliferation and inhibiting apoptosis among other mechanisms [110]. Anti-
inflammatory agents are considered to be potential chemopreventives [110, 
183, 195]. Due to the focal role of NF-B in the regulation of inflammation [15], 
restricting its activation has been among the targets of recent chemoprevention 
studies [110, 195].  
Grey et al. [69] evaluated the levels of ursolic acid in 24 cultivars and advanced 
selections of sea buckthorn berries. Three of them, having low (H. rhamnoides 
‘Bhi 10941’), medium (H. rhamnoides ‘Bhi 10726’) and high (H. rhamnoides 
‘Podaruk Sadu’) contents of usolic acid were used for the proliferation 
experiments. Initially berry extracts were prepared using several different 
solvents. For further tests only the most potent fractions produced by ethyl 
acetate and two different ethanol-water extractions were chosen. Sea 
buckthorn extract concentrations from <0.1% to 2% v/v in the medium were 
used. The ursolic acid rich ethyl acetate fraction had the strongest 
antiproliferative effect in the colon cancer cells, whereas the ethanol-water 
extract had the strongest antiproliferative effect in the liver cancer cells. For the 
ethyl acetate fraction, an apoptosis inducing effect was observed as well. The 
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study was carefully conducted and the results were expressed in relation to the 
control. The contents of the main phenolics and ursolic acid in the extracts 












Figure 8. Ursolic acid 
In the study by Boivin et al. [23], sea buckthorn juice (H. rhamnoides cv. Sunny) 
was among the berry juices that strongly inhibited the proliferation of human 
intestinal, breast, prostate and stomach cancer cells in vitro at a level of 50 juice 
μl/ml medium. For prostate and breast cancer cells the effect was dose 
dependent at concentrations from 10 to 50 μl/ml medium. As reviewed in the 
previous chapter, the anti-inflammatory effect of sea buckthorn juice was 
observed in this study as well. All the 13 berry samples tested had antioxidant 
activity. The antioxidativity did not, however, correlate with the antiprolifative 
effects.  
Olsson et al. [147] stress the potential of the synergestic effects of vitamin C 
and other berry components in preventing the proliferation of colon and breast 
cancer cells. They studied the effects of ten fruit and berry fractions in vitro. 
The sea buckthorn sample was H. rhamnoides species of unknown origin from 
the Balsgård assortment, extracted with ethanol-water. An advantage 
compared to most other studies, was the detailed reporting of the chemical 
compositions of the fruit and berry extracts used [147]. Sea buckthorn was 
among the strongest inhibitors of cancer cell proliferation at the highest 
concentrations tested (0.25 and 0.5 % of plant dry material/ total weight of the 
test medium). Across the berries and fruits of the study, there was an inverse 
relationship between the vitamin C content and breast and liver cancer cell 
proliferation. At the second highest concentration (0.25 %) of fruit/berry 
extracts tested, there was an inverse association between lutein and β-carotene 
content and the proliferation of the breast cancer cells. The authors point out 
that the levels of the bioactive plant compounds in this study were within the 
range that can be found in human tissues.  
Teng et al. [206] used isolated sea buckthorn isorhamnetin in their study, 
aiming to investigate its efficacy against human hepatocellular carcinoma cells. 
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From the article it was not completely clear whether sea buckthorn berry or 
some other part of H. rhamoides, like the leaves were used for the isolation of 
isorhamnetin. Concentrations of 25 - 300 μg isorhamnetin/ml medium were 
used. It was found that isorhamnetin could permeate into the cancer cells and 
reduce their viability in a dose- and time-dependent manner. Isorhamnetin at a 
level of 50 μg/ml induced the fragmentation and condensation of chromatin in 
the cells. Chromosomal condensation is thought to preceed the formation of 
apoptotic bodies. When the amount of apoptotic cells was investigated using 
flow cytometry, signs of increased apoptosis induced by isorhamnetin was 
observed. However, the authors point out that the concentrations used in their 
study were high compared to the levels observed in vivo.  
Padmavathi et al. [151] studied chemoprevention by sea buckthorn in mice. 
Berries of H. rhamnoides ssp. Turkestanica were extracted using ethanol to 
produce the fraction given by oral gavage to the mice. Doses from 150 to 300 
mg/kg body weight were given for 2 - 6 weeks, depending on the experiment. 
The mice were admistered the berry extracts before the chemical induction of 
skin or forestomach papillomagenesis. In the skin papillomagenesis test, the 
intake of sea buckthorn extract was continued during the first weeks of 
induction of papillomas. Additionally, the effect of sea buckthorn on liver 
enzymes was investigated by giving the mice the sea buckthorn extract for 14 
days at a dose of 150 or 300 mg/kg body weight. A total of 45 - 60 mice 
including a control group were included. Sea buckthorn extract inhibited the 
incidence of skin and forestomach tumours induced by 7,12-dimethyl-
benzathracene and benzo(a)pyrene, respectively. The liver phase II enzymes 
catalyse the conjugation of xenobiotics to another molecule. This may change 
the activity of the xenobiotic and change it into an excretable form. The 
ethanolic extract of sea buckthorn induced the activity of phase II and 
antioxidant enzymes in the liver. It also induced the transcription factor 
interferon regulatory factor-1 (IRF-1), which has been shown to possess 
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2.2.4 Antimicrobial properties 
The antimicrobial effects of berries, sea buckthorn among them, have been 
investigated extensively by Puupponen-Pimiä et al. [142, 165, 166]. As 
summarized in Table 5, sea buckthorn berry and/or the phenolic fractions of 
berries and seeds have in vitro anti-bacterial activity against several bacteria, 
including strains of human pathogenic Salmonella enterica, Escherichia coli and 
Staphylococcus aureus. No effects on the growth of probiotic bacteria were 
observed [142, 165, 166]. The suggested antibacterial mechanisms of berry 
compounds include disruption of the outer membrane of bacterial cell walls 
(gram negative bacteria) and mutagenic effects on bacterial DNA [142, 166].  
Compared to the individual flavones, flavonols, flavanones, anthocyanidins 
and phenolic acids tested by Puupponen-Pimiä et al. [166], the inhibition of 
bacteria by berry extracts was stronger. This suggests effects of complex 
compounds, such as ellagitannins (hydrolysable tannins) or proanthocyanidins 
(condensed tannins), and/or synergy between several berry components [166]. 
Though showing antimicrobial activity, sea buckthorn was among the weakest 
berry inhibitors of bacterial growth in vitro, whereas cloudberry and raspberry 
consistently showed high efficacy [142, 165, 166]. This may be due their high 
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2.2.5 Wounds, skin and mucosa 
Results from animal studies indicate that oral and topical sea buckthorn seed 
oil and topical sea buckthorn flavonoids can significantly promote the healing 
of wounds (Table 6) [72, 216]. Both sea buckthorn oil and flavonoids increased 
the antioxidant levels in the wound and reduced the levels of reactive oxygen 
species and/or markers of oxidation [72, 216]. The effects on inflammation were 
suggested as well. Inflammation is needed for healing of the wound, to 
prevent infections in it, and to induce the proliferation phase of the healing. 
However, excessive and long lasting inflammation is detrimental and leads to 
tissue damage [216].  
Upadhyay et al. [216] investigated the effects of CO2-extracted seed oil on burn 
wounds in rats. The wild H. rhamoides berries for the extraction of the oil were 
collected from the Western Himalayas. Even though the study was otherwise 
carefully conducted and reported, the composition of the particular oil used in 
this study was not analysed. Instead, for the composition of the oil the reader 
was referred to a previous article published two years earlier. An intial 
screening for the optimal dose and route of admistration was carried out by 
giving the rats oral doses of 1.0 - 5.0 ml oil/kg body weight for 7 days after 
creating burn wounds. The second group of rats was treated with applying 
topically doses of 100 - 400 μl oil/wound for 7 days after creating the wounds. 
Based on this, a combination of oral oil (2.5 ml oil/kg body weight/day) and 
topical oil (200 μl oil/wound/day) was used for the experiments (admistration 
of oil for 7 days after generation of the burn wound). In addition to the sea 
buckthorn group, positive and negative control groups were included (6 - 8 
rats/group).  
Co-admistration of topical and oral sea buckthorn oil was found to enhance 
wound healing as indicated, among others, by increased wound contraction 
and increased amount of hydroxyproline (component of collagen) in the tissue. 
The sea buckthorn oil treated wounds showed reduced oedema or no oedema, 
indicating attenuation of the inflammation. Up-regulated expression of the 
vascular endothelial growth factor (VEGF) indicated the induction of 
angiogenesis by the oil. Histopathological findings supported the positive 
effects of sea buckthorn oil on the regeneration of tissue in the wounds. Sea 
buckthorn oil reduced the amount of ROS and increased the amount of 
reduced glutathione in the wound granulation tissue. The authors suggest that 
the improved wound healing induced by sea buckthorn oil may be due to the 
antioxidant activity as one of the mechanisms involved [216].  
Topical sea buckthorn berry flavonoids had similar positive effects on dermal 
wounds in the study of Gupta et al. [72]. H. rhamnoides flavonoids obtained 
from a Chinese company were mixed in propylene glycol base at concentration 
of 2%. The total polyphenolic content of the flavonoid preparation was 
reported, but no other details of the extraction methdods, origin of berries or 
chemical composition were presented. A total of 24 rats were divided into 
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control and experimental animals. In the sea buckthorn group, 20 μl of the 
flavonoid rich base were applied topically to the wounded area for 7 - 16 days 
after the creation of the wounds. The sea buckthorn flavonoids were found to 
promote the wound healing as indicated by improved wound contraction, 
faster epithelialization and increased levels of hydroxyproline and hexosamine 
(indicating collagen production and stabilization) in the wound tissue.  Also 
the antioxidant status in the wound tissue was increased by sea buckthorn 
flavonoids and the levels of lipid peroxides were lower compared to the 
control. The histopathological evaluation of the wounds showed a greater rate 
of tissue regeneration compared to the control. Vitamin C was among the 
antioxidants, the levels of which were greater in the sea buckthorn group 
compared to that of control.   This may be due to presence of vitamin C in the 
sea buckthorn extract or the flavonoids may aid its preservation. Vitamin C is 
essential for collagen synthesis [72].  
A clinical, randomized, placebo-controlled study by Yang et al. [231] (Table 6) 
indicates that CO2-extracted sea buckthorn seed and pulp oil may beneficially 
affect atopic dermatitis characterized by dry and itchy skin and inflamed 
eczema lesions. Atopic dermatitis arises from possibly genetic disturbances in 
the epidermal function and/or immune system. Due to the essential role of 
long-chain n-3 and n-6 polyunsaturated fatty acids as eicosanoid precursors in 
the regulation of inflammation, they are hypothesized to be involved in the 
development of atopy.  Atopic patients may have a deficiency in Δ6-desaturase, 
the enzyme converting α-linolenic acid and linoleic acid to stearidonic and γ-
linolenic acids, respectively (Figure 4). In addition, polyunsaturated fatty acids 
are components of sphingolipids contributing to the water barrier properties of 
the epidermis [231].  
A total of 78 women and men were randomized to Yang’s study [231]. Forty-
nine of them completed and were included in the statistical analyses. 
Supercritical CO2-extraction of H. rhamnoides seeds and combined berry flesh 
and peels were used for production of the study oils. Paraffin oil was used as a 
placebo. The fatty acid compositions of the oils were reported in the article. 
The participants daily took 5 g of sea buckthorn seed oil, sea buckthorn soft 
part oil or a placebo for four months. During the intervention, the severity of 
the atopic dermatitis was evaluated by the SCORing Atopic Dermatitis 
(SCORAD) index, and blood samples were collected for the determination of 
plasma fatty acids, lipid and immunoglobulin E (IgE) levels.  
The atopic dermatitis symptoms at the end of the intervention were 
significantly milder in the pulp oil and placebo (paraffin oil) groups compared 
to the baseline. The seed oil group had a trend towards milder symptoms as 
well, but the changes were not significant. The proportion of α-linolenic acid 
increased significantly in the plasma neutral lipids in the seed oil group from 
baseline to the end. There was an almost significant increase in the proportions 
of α-linolenic, linoleic and eicosapentaenoic acids in the plasma phospholipids. 
The increases of α-linolenic acid in both lipid classes in the seed oil group were 
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significantly positively correlated with the improvement of symptoms. The 
changes of plasma fatty acid proportions in the pulp oil group (increase of 
palmitoleic acid and decrease of pentadecanoid acid in phospholipids) did not 
correlate with the symptoms. There were no changes in the levels of plasma 
IgE [231]. The authors suggest that the lack of significance for the symptom 
effects in the seed oil group may be due to the small number of participants 
and mild symptoms at baseline. As the fatty acids of the pulp oil did not 
correlate with the symptoms, it is likely that other components contributed to 
the positive effects, and the anti-inflammatory potential of plant sterols was 
pointed out by the authors. The changes in the paraffin oil group indicate a 
significant placebo effect [231].  
In their subsequent study, Yang et al. [232] investigated the effects of sea 
buckthorn seed and pulp oils on the fatty acid composition of skin 
glycerophospholipids of patients with atopic dermatitis. A randomized, 
parallel, placebo-controlled, double-blind design was used in the trial of 22 
volunteers. The same oils and doses were used as in their study reviewed 
above [231]. The oil intervention lasted for four months. Skin biopsies for the 
analysis of fatty acid composition were taken at baseline and at the end of the 
intervention. Neither the seed nor the pulp oil induced significant changes in 
the glycerophospholipids of the skin [232] (Table 6). In the seed oil group, a 
trend towards increased proportion of eicosapentaenoic acid and decreased 
proportion of palmitic acid in the skin glycerophospholipids was observed. 
Additionally, the seed oil induced a significant increase in plasma linoleic acid. 
In the placebo group consuming paraffin oil, a nonsignificant (0.05 < P < 0.1) 
increase in the plasma concentrations of stearic and linoleic acids was 
observed. The authors concluded that the fatty acid composition of the skin 
glycerophospholipids is not easily affected by short-term dietary 
supplementation [232]. 
Two clinical studies by Yang and Erkkola [229] indicate the beneficial effects of 
sea buckthorn oil on the symptoms of vaginal inflammation and Sjögren’s 
syndrome, an inflammatory autoimmune disease causing dryness, pain and 
inflammation in the mucous membranes. These trials had a low number of 
participants (five cases in the vaginal inflammation study and 25 in the 
Sjögren’s syndrome study), but gave positive indications to further studies. 
These studies were carried out using a strandardized CO2-extracted H. 
rhamnoides oil containing both pulp and seed oils.  
In the vaginal inflammation study, the five women (35 – 79 years of age) 
participating had a history of vaginal inflammation symptoms for several 
years and had not benefited from earlier hormone replacement therapy or local 
corticoids. They consumed daily 3 g of sea buckthorn oil orally for 12 weeks. 
Three of the women, having the most severe symptoms at baseline, reported 
clear improvement of the vaginal inflammation symptoms. One participant 
reported a slight improvement and one participant did not report changes. The 
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estrogen levels were not affected by the intervention. Due to the small number 
of participants, statistical analyses were not performed [229].    
In the double-blind study concentrating on Sjögren’s syndrome [229] 25 
women (37 - 66 years of age) were randomized to receive sea buckthorn or a 
placebo (fractionated coconut oil) in a cross-over manner. The 
supplementation for each oil lasted for three months at a dose of 3 g/day. The 
symptoms of Sjögren’s syndrome were evaluated using a visual analogue scale 
and by verbal description at the beginning of the study, at the end of the first 
intervention period, and at the end of the second intervention period. The 
participants reported an improvement of symptoms in both sea buckthorn and 
placebo groups from baseline to the end of the intervention. Clear differences 
between the sea buckthorn and placebo groups were seen in the percentage of 
participants reporting improvement of overall symptoms of Sjögren’s 
syndrome after the first three months of the study. A significantly higher 
percentage of participants reported improvement in overall symptoms in the 
sea buckthorn group compared to the placebo. Among the individual 
symptoms positively affected by sea buckthorn were dryness of eyes and 
mouth (results of statistical analyses for individual symptoms not reported). 
When both of the three month intervention periods were included, a 
significantly greater proportion of the participants in the sea buckthorn group 
reported improvement in the symptoms of the genital tract, including itching 
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2.2.6 Gastric ulcer 
Preventive and curative effects of sea buckthorn oils against gastric ulcers have 
been reported in rats (Table 7) [198, 227]. Süleyman et al. [198] investigated the 
effects of hexane extract from H. rhamnoides berries given orally by gavage before 
the induction of gastric ulcers by stress or by indomethacin. The origin of the 
berries, exact method of extraction, or the chemical composition of the sea 
buckthorn extract was not reported in the article. The rats in the sea buckthorn 
group were given 1 ml extract/kg body weight as a single dose. Positive and 
negative control groups were included in the experiments (n = 6 - 8 rats/group). 
The sea buckthorn oil admistration significantly reduced the number and size of 
ulcerative areas when the ulcer was induced either chemically or by stress. Stress 
and oxygen radicals contribute to the pathogenesis of gastric ulcers. The authors 
suggest that the hexane soluble components of sea buckthorn berry, including 
vitamin E and carotenoids, have cumulative antioxidantive effects that 
contribute to the prevention of mucosal injury.  
Xing et al. [227] admistered CO2-extracted seed and pulp oils of wild H. 
rhamnoides berries collected from Romania to rats to investigate the effects on 
gastric ulcers. The fatty acid composition and sitosterol, carotenoid, tocotrienol 
and tocopherol content of the oils were reported in the article. Daily doses of 
3.5 or 7.0 ml oil/kg body weight were orally admistered to the rats for 7 - 12 
days before or after the induction of gastric ulcers. Positive and negative 
control groups were included (n = 10 rats/group). Four methods for the 
induction of ulcers were used: water immersion stress, reserpine, pylorus 
ligation (sea buckthorn oils given before induction of ulcers) and acetic acid 
(sea buckthorn oils given after induction). In all experiments both seed and 
pulp oils had a positive effect against ulcer formation. In the case of water 
immersion and reserpine induction, a higher dose of 7 ml/kg was needed for 
significant effect. Significant protective and curative effects were observed at a 
dose of 3.5 ml/kg in the pylorus-ligation and acetic acid experiments, 
respectively. As both sea buckthorn seed and pulp oils were effective, it is 
likely that fatty acids are not the only components contributing to the effects. 
The authors suggest it is the inhibition of lipid peroxidation in gastric mucosa 
by the sterols, carotenoids and tocols in the oils. Sea buckthorn oil has been 
shown to promote wound healing in the skin [72, 216], and similar 
mechanisms may be important in the healing of the gastric mucosa as well.  
Helicobacter pylori infection is associated with chronic inflammation, 
accumulation of reactive oxygen species, oxidative damage to gastric mucosa 
and increased risk of gastric ulcer [203]. Ethanol extracts of sea buckthorn 
leaves were reported to inhibit the growth of H. pylori in vitro [115], but this 
effect has not been reported for sea buckthorn berry or berry fractions in the 
journals published in English. Nohynek et al. [142] reported strong in vitro H. 
pylori inhibition by phenolic extracts of cloudberry, bilberry, black currant, 
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2.2.7 Hepatotoxicity and liver fibrosis 
Excessive alcohol consumption, virus infections, alterations in lipid and 
carbohydrate metabolism and xenobiotics, among others, induce liver damage. 
Reactive oxygen species are focal in the initiation and progression of the 
damages in all of the above-mentioned etiologies [131]. According to Hsu et al. 
[88] sea buckthorn seed oil has convincing potential against hepatotoxicity 
induced by carbon tetrachloride (CCl4) in mice (Table 8). Cytochrome P-450, a 
phase I enzyme in the xenobiotic metabolism, catalyses the transformation of 
CCl4 to trichloromethyl radical (CCl3∙) and trichloromethyl peroxyl radical 
(CCl3O2∙), which can initiate peroxidation of membrane lipids, and ultimately 
lead to cell necrosis. 
In Hsu’s [88] study, which was otherwise conducted and reported very 
carefully, the information concerning the study oil was quite cursory. They 
report using commercial H. rhamnoides seed oil containing mainly linoleic and 
oleic acid. It was given orally for eight weeks at doses of 0.26 - 2.6 mg/kg body 
weight after exposing the the mice with CCl4. Olive oil was used as a normal 
control and silymarin (a flavonolignan complex extract from Silybum 
marianum) was used as a positive control. Sea buckthorn oil protected the mice 
against the CCl4-induced elevation of serum alanine aminotransferase (ALAT), 
aspartate aminotransferase (ASAT), alkaline phosphatase, and triacylglycerols. 
It restricted the CCl4-induced rise of body and liver weight which were 
considered as signs of hypertrophy of the liver tissue. The effects of sea 
buckthorn oil on hepatotoxicity were not dose-dependent, and a dose of 0.26 
mg/kg bw/day was chosen to be the optimal one, equating a dose of only 15.6 
mg/day for a person of 60 kg. Sea buckthorn oil significantly protected against 
a decrease of glutathione, superoxide dismutase, glutathione peroxidase and 
glutathione reductase in the liver, and the rise of malonialdehyde (a biomarker 
of lipid peroxidation) concentration, indicating protective effects due to 
enhanced antioxidative protection. [88].  
Gao et al. [60] (Table 8) investigated the effects of sea buckthorn extract in 50 
patients having liver fibrosis. The authors conclude that sea buckthorn may be 
a drug candidate for the prevention and treatment of liver fibrosis, and 
encourage further clinical trials on the topic. However, they did not specify 
which part of the plant was used for the preparation of sea buckthorn extract 
investigated, which was the extraction solvent used, and what was the 
composition of the extract. Better normalization rates of the serum ALAT and 
ASAT activities were reported for the sea buckthorn group compared to the 
control. However, the baseline values of ALAT differed greatly between the 
groups, being more than two times higher in the control group. A reduction of 
collagen production markers in serum was reported. The results concerning 
some of the other markers, including serum TNF-α and IL-6 were vaguely 
presented.   
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2.2.8 Risk factors associated with cardiovascular diseases and diabetes 
2.2.8.1 Endothelium 
Several studies indicate that sea buckthorn beneficially affects the risk factors 
associated with cardiovascular diseases and diabetes (Tables 9 and 10). Bao & 
Lou [12] investigated the potential of sea buckthorn flavonoids against 
endothelial damage by oxidized low density lipoprotein (ox-LDL) in vitro. 
Endothelial dysfunction caused by ox-LDL contributes to pathogenesis of 
atherosclerosis. Ox-LDL induces changes in the secretory activities, consumes 
the antioxidant capacity and decreases NO synthesis in the endothelium. 
Synthesis of NO is critical to the normal function of endothelial cells. It 
mediates relaxation of smooth muscle and inhibits platelet activation [12, 13]. 
Though NO can react with superoxide to form peroxynitrite capable of LDL 
oxidation [207], it can also quench superoxide depedending on the 
environment [12, 13, 207].  
Ox-LDL activates lectin like ox-LDL receptor-1 (LOX-1) in endothelial cells. 
Activation of LOX-1 leads to the activation of intracellular pathways including 
protein and tyrosine kinases and mitogen activated protein kinases (MAPK). 
These pathways contribute to the activation, dysfunction and apoptosis of 
endothelial cells. NF-B is among the transcription factors whose activation is 
mediated by the MAPK cascades. Endothelial constitutive nitric oxide synthase 
(eNOS), whose expression is reduced due to LOX-1 activation is among the 
target genes of NF-B [12, 13]. Ox-LDL decreases the levels of superoxide 
dismutase responsible for maintaining physiological levels of superoxide and 
increases the levels of reactive oxygen species making the cells vulnerable to 
oxidative damage [12, 13].  
Bao & Lou [12] studied the potential of H. rhamnoides berry flavonoids against 
ox-LDL injuries in endothelial cells in vitro. The main components of the 
flavonoid preparation were quercetin and isorhamnetin. Concentrations of 9.38 
- 37.5 μg sea buckthorn flavonoids/ml medium were used for the experiments 
of the study. ox-LDL induced endothelial cell deaths and secretion disorders 
(increase in the release of lactate dehydrogenase (LDH) and a reduced 
concentration of NO). It induced the production of superoxide, suppressed the 
content of superoxide dismutase, inhibited the expression of eNOS and 
increased the expression of LOX-1 in the endothelial cell culture. Sea 
buckthorn flavonols added to the medium before treatment with ox-LDL had a 
preventive effect against all of the above mentioned effects of ox-LDL. For the 
most protective effects, a concentration of 18.75 μl flavonoids/ml was required. 
Quercetin and isorhamentin as single components had similar protective 
potential as the sea buckthorn flavonoid mixture. In general, the effects of 
quercetin were more pronounced than those of isorhamnetin. As the authors 
note, reasonably high concentrations of flavonoids were used in the trial. 
However, the viability of the cells was not affected [12].  
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Regardless of the impressive in vitro effects of sea buckthorn flavonoids on 
endothelial cells by Bao & Lou [12], the flavonoid rich sea buckthorn juice 
failed to show effects on intracellular adhesion molecule-1 (ICAM-1) in a 
randomized double-blind placebo-controlled clinical study by Eccleston et al. 
[53]. ICAM-1 is involved in the endothelial recruitment of monocytes into 
areas of inflammation. In the vascular walls, the infiltrated monocytes can 
internalize and scavenge oxidized LDL and be transformed to lipid rich foam 
cells, contributing to development of atherosclerotic plaque. During the study, 
the healthy male participants (a total of 30 men) daily consumed either 300 ml 
of commercial sea buckthorn juice or placebo juice for eight weeks. Blood 
samples for analyses of risk factors for cardiovascular disease were collected at 
the beginning and end of the intervention [53].  
2.2.8.2 Platelet aggregation and thrombosis 
The effects of sea buckthorn on platelet aggregation and thrombosis have been 
studied in vitro, in animals [37] and in clinical trials [53, 96] (Tables 9 and 10). 
The animal and in vitro study by Cheng et al. [37] concentrated on the effects of 
sea buckthorn flavonoids extracted from H. rhamnoides berries by methanol 
and ethyl acetate. The chemical composition of the extract was not presented in 
the paper. In the thrombosis aggregation experiment, the mice were given 100 
– 300 μg flavonoids/kg body weight intravenously 15 min before inducing the 
formation of thrombus by photochemical reaction between intravenously 
injected rose bengal and green light irradiation. Aspirin was given to the mice 
in the positive control group. The number of mice was 6 - 8 /group. The 
flavonoid treatment at a dose of 300 μg /kg significantly prolonged the 
thrombotic occlusion time. The effect was similar to that of 10 mg/kg aspirin.  
In Cheng’s study [37], the anti-aggregation potential of sea buckthorn was 
investigated in vitro using flavonoid concentractions of 0.3 - 3.0 μg/ml medium. 
The flavonoids prevented platelet aggregation induced by collagen, but not 
those by adenosine diphosphate (ADP) or arachidonic acid. The authors 
suggest that sea buckthorn flavonoids inhibit platelet aggregation by 
suppressing the release of arachidonic acid from cell membrane phospholipids. 
Stimulation of collagen receptors leads to the activation of tyrosine kinase, 
which in turn leads to an increase in intracellular calcium and the activation of 
phospholipase A2 [37]. Arachidonic acid released from the phospholipids by 
phospholipase A2 is a precursor for thromboxanes A2 and B2 having 
vasoconstricting and platelet activating effects [188]. 
Johansson et al. [96] observed a platelet aggregation inhibitive effect of CO2-
extracted sea buckthorn oil in their cross-over study in healthy normolipidemic 
men. The duration of the two randomized treatment periods was four weeks 
and they were separated by a wash-out period of four to eight weeks. During 
their sea buckthorn period the participants consumed daily the combined sea 
buckthorn seed and pulp oil from H. rhamnoides berries at a dose of 5 g/day. 
During their placebo period, they took 5 g of fractionated coconut oil rich in 
Review of the Literature 
 
54 
medium chain fatty acids. The fatty acid compositions of the oils were reported 
in the article. A total of 12 volunteers participated in the study. The combined 
sea buckthorn seed and pulp oil decreased the rate and maximum of ADP 
induced platelet aggregation compared to the placebo. There was no effect 
seen on plasma lipids, fatty acid composition of plasma and platelet 
phospholipids or on platelet aggregation induced by arachidonic acid [96].  
Sea buckthorn berry juice (300 ml/day for eight weeks) did not affect platelet 
aggregation induced by any of the aggregation agonists tested (ADP, collagen, 
arachidonic acid) in the clinical placebo-controlled, double-blind, randomized, 
parallel study by Eccleston et al.  [53] (Table 10 & Chapter 2.2.8.1: more details 
of the study). Even though a small decrease in platelet aggregation over the 
study period was observed, this was evident in both sea buckthorn and 
placebo, and the groups did not differ significantly. The blood aggregation 
assays were conducted at the beginning and end of the intervention period.  
2.2.8.3 Circulating lipids 
The effects of sea buckthorn on circulating lipids have been investigated in 
several clinical trials and in an animal study (Tables 9 and 10). Basu et al. [17] 
investigated the antiatherogenic effects of sea buckthorn seed oil in rabbits. 
CO2-extracted seed oil from the wild H. rhamnoides berries from Western 
Himalayas was orally admistered to rabbits at a dose of 1 ml/ day. The 
composition of the particular oil in question was not reported. Instead the 
authors cite a previous article. One group of rabbits received the seed oil for 18 
days with a normal diet. Another group received the oil for 30 days in 
combination with a high-cholesterol diet after an initial period with a high 
cholesterol diet. Control groups getting only the high cholesterol diet and 
normal diet were included in the trial as well. The number of animals was five 
per group.  
In the study by Basu et al. [17], sea buckthorn oil induced desirable changes in  
the lipid markers in the rabbits fed a normal diet in combination with sea 
buckthorn oil.  In this group there was a decrease in plasma LDL cholesterol, 
atherogenic index [(total cholesterol - HDL cholesterol)/HDL cholesterol)] and 
LDL/HDL ratio. Additionally, a rise in HDL cholesterol and the ratio of HDL 
cholesterol/total cholesterol was observed. These changes were significant 
from the baseline. However, it was not completely clear from the article, 
whether the effect was significant as compared to the control group. A 
significant vasorelaxant effect was observed [17]. In the rabbits getting the 
cholesterol rich diet, normalization of plasma LDL cholesterol in the sea 
buckthorn group was better compared to the placebo. Compared to the 
beginning of the seed oil intervention, several other lipid markers were 
positively affected as well. Sea buckthorn oil induced a significant vasorelaxant 
effect in the cholesterol-fed animals. The authors suggest that vasorelaxation 
may be due to the modification of NO production. The positive effects on 
plasma cholesterol levels may be caused by the phytosterols of the oil [17].  
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The effects of sea buckthorn oil on plasma cholesterol and triacyglycerols have 
been less consistent in clinical trials (Table 10). In their study concerning the 
effects of combined sea buckthorn seed and pulp oil (5 g/day for four weeks) 
Johansson et al. [96] did not detected effects on plasma triaglycerols and total, 
HDL or LDL cholesterol in normolipidemic men (study described in more 
detail in Chapter 2.2.8.2). Yang et al. [231] investigated the effects of sea 
buckthorn seed and pulp oils (5 g/day for four months) on atopic dermatitis. In 
the pulp oil group there was a significant increase in the plasma HDL 
cholesterol concentration from the baseline to the end of the intervention. Total 
or LDL cholesterol or triacylglycerols were not affected [231] (study described 
in more detail in Chapter 2.2.5). Sea buckthorn juice (300 ml/day for eight 
weeks) caused a nonsignificant increase in serum HDL cholesterol and 
triacylglycerols, but did not affect levels of LDL cholesterol in healthy men 
[53]. Also a nonsignificant increase in resistance to LDL oxidation was found in 
the study by Eccleston et al. [53] (study described in more detail in Chapter 
2.2.8.1). 
Suomela et al. [201] studied the effects of sea buckthorn nonglycosidic 
flavonols on markers of cardiovascular disease risk. Flavonols of sea buckthorn 
berry pulp (origin not defined) were extracted with ethanol-water. The oil was 
removed from the extract with hexane. The sugars were removed using water 
extraction. A total of 14 healthy males with slightly elevated total cholesterol 
levels were randomized to the double-blind, placebo controlled cross-over 
study. During the sea buckthorn period of four weeks the participants daily 
consumed 400 mg of the sea buckthorn extract containing 78 mg of 
nonglycosidic flavonols with oatmeal porrige. The main flavonols present were 
isorhamnetin, quercetin and kaempferol. The intake of flavonols did not affect 
the serum and plasma levels of oxidized LDL, total, HDL or LDL cholesterol, 
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2.2.8.4 Hypertension and blood glucose 
Pang et al. [152] (Table 9) investigated the effects of sea buckthorn flavonoids 
from seed residues on hypertension, reduced insulin sensitivity and other 
undesirable changes induced by the large intake of sugar in rats. The seed 
flavonoid extracts were prepared from H. rhamnoides berries collected in 
Mongolia. The composition of the extract was not presented in the paper. A 
total of 66 rats were used in the trial including three sea buckthorn groups with 
different doses (50 – 150 mg flavonoids/ kg body weight/ day and positive and 
negative control groups. The rats were fed for six weeks a sucrose rich diet and 
after that supplemented with sea buckthorn flavonoids while still under the 
sucrose diet for another eight weeks. The sea buckthorn flavonoids induced a 
lowering of hypertension induced by sucrose, recovery of insulin sensitivity, 
and decrease in insulin levels [152]. 
In Pang’s study [152] the sucrose feeding increased the levels of blood pressure 
rising angiotensin II hormone in the heart and kidneys. The levels of 
angiotensin II in the blood were unaffected. In the flavonoid-supplemented 
group, the levels of angiotensin II in the plasma increased, while the levels in 
the heart and kidneys were unaffected. With the highest dose of sea buckthorn 
flavonoids, the increase in the plasma was similar to that of ibertasan, an 
angiotensin II receptor antagonist used for the treatment of hypertension. The 
levels of angiotensin II in the heart and kidneys were not affected by ibesartan 
either. The above results indicate that sea buckthorn flavonoids may block 
angiotensin II receptors on the cell surface and keep it in the plasma, and by 
this mechanism reduce the blood pressure [152]. Angiotensin II preventing 
drugs may enhance insulin sensitivity, though the mechanism of the effect is 
still under investigation. Attenuative effects on inflammation and oxidative 
stress, among others, have been suggested. Angiotensin II receptor blockers 
have been found to inhibit the enzymes promoting oxidative stress [92].    
Zhang et al. [240] (Table 9) studied the effects of water extract from sea 
buckthorn seed residue in diabetic rats. The H. rhamnoides ssp. sinensis seeds 
were obtained from berries collected from Inner Mongolia. The total flavonoid 
content of the hot-water extracted residue was 1.13%. The total content of 
carbohydrates was 3.52%. A total of 48 rats were included in the study. In 36 of 
them type 1 diabetes was induced by the admistration of oxygen radical 
producing streptozotocin. Four groups of 12 rats were monitored: a normal 
control group, a diabetic control group, a diabetic positive control group and a 
diabetic sea buckthorn group. The sea buckthorn group was orally 
supplemented with 400 mg of seed residue/ kg body weight daily for four 
weeks. Sea buckthorn extract had a hypoclycaemic effect in the diabetic rats. 
The effect was comparable to that of the positive control drug glibenclamide. 
Unlike glibenclamide, the sea buckthorn extract did not raise the insulin levels 
of the diabetic rats, indicating that the sea buckthorn effect was not due to the 
stimulation of insulin secretion. The seed extract induced a reduction of serum 
triacylglycerols as well. A restoration of the antioxidant systems in the diabetic 
Review of the Literature 
 
59 
rats by sea buckthorn was observed. The authors suggest that sea buckthorn 
extract may be useful in preventing diabetes complications by antioxidant and 
triacylglycerol lowering mechanisms [240] .  
In Johansson’s study [96] (see Table 10 and Chapter 2.2.8.2 for more details of 
the study protocol) concerning the effects of sea buckthorn oils in healthy men 
(5 g/day for four weeks), the fasting blood glucose levels were slightly elevated 
during the supplemention with both the placebo oil and the sea buckthorn oil. 
The authors suggest that this could be explained by the increased fat intake 
during the intervention.  
2.2.9 Safety  
According to Tulsawani [212], the No Observed Adverse Effect Level 
(NOAEL) of water extract of sea buckthorn berry in rats administered by 
gavage for 90 d is 100 mg/kg body weight/ day. The extract used in their study 
was prepared with H. rhamnoides berries collected from the Indian Himalayas. 
The total phenolic content was 50.5 mg/g as a gallic acid equivalent. No 
mortality or changes in the general behavior of the animals (15 mice in four 
groups, admistered 0 - 500 mg extract/kg/day) were observed, even at the 
highest doses used. Sea buckthorn extract in any of the doses did not induce 
significant changes to the mean body weight, to the organ/body weight ratio, 
or to the large variety of histological, hematological and biochemical 
parameters monitored in the rats as compared to the control group. However, 
intakes of 250 and 500 mg/kg induced an elevation in plasma glucose. The 
author suggests that the rise in plasma glucose was due to the sugars in the 
water extract. Even though the glucose elevation was restored within two 
weeks after the end of the sea buckthorn treatment, a NOEL level of 100 
mg/kg/day for long term supplementation was decided.  
Chawla et al. [35] reported a maximum tolerable dose of 200 mg/kg body 
weight/day for flavonoid rich ethanol extract of sea buckthorn berries 
admistered intraperitoneally as a single dose for mice. Doses above 200 mg/kg 
induced mortality. At a dose of 212 mg/kg 50% of the animals died within 72 h. 
The extract used by Chawla et al. [35] was prepared from H. rhamnoides berries 
collected from the Western Himalayas.  
Goel et al. [65] (Table 2) investigated the acute toxicity of alcoholic sea 
buckthorn berry extract RH-3, which was administered intraperitonially to 
mice as single doses of different sizes. For two days after the intake of RH-3, 
effects on survival, behavior, neuromuscular co-ordination and the respiratory 
tract were monitored, among others. Detailed results of the individual assays 
were not presented, but the authors state that single doses of up to 40 mg/kg 
body weight were tolerated and the only apparent adverse effect was 
drowsyness for 3 - 5 minutes after intake. Doses of 45 mg/kg body weight or 
higher caused increased mortality in a dose dependent manner.  
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As a part of their study concerning the effects of CO2-extracted sea buckthorn 
seed oil on burn wounds, Upadhyay et al. [216] (Table 6) investigated the 
toxicity of the oil. In the acute oral toxicity test, the rats were given single doses 
of 2.5 - 10 ml sea buckthorn seed oil/kg body weight and symptoms of toxicity 
(mortality, signs of severe toxic symptoms) were monitored for 14 days. In the 
sub-acute oral toxicity test, sea buckthorn seed oil was daily admistered to the 
rats at doses of 2.5 or 5.0 ml/kg body weight for 14 days. In addition, the 2.5 
ml/kg dose chosen for the wound healing experiments was fed for a group of 
rats for 28 days to monitor the signs of any sub-acute toxicity. For the 
evaluation of sub-acute toxicity, organ/body ratios and several biochemical 
and hematological parameters were analysed. No signs of acute toxicity were 
observed at any of the doses tested, and the results of the biochemical and 
hematological analyses did not significantly differ between the treatment and 
control groups (six rats per group).  
In many of the health effect studies, the composition of the extract or other 
product used is not reported. In some cases even the method of extraction or 
the solvents used are described in a cursory manner only. In studies where the 
compositions of the ethanol/water extracts or flavonoid preparations have 
been reported, the amounts of the alledged active components have varied 
greatly [69, 193, 201, 240].  Therefore it is not easy to compare the results of the 
safety evaluations between studies. Flavonoids from different sources have 
been associated with effects on the metabolism of certain drugs, and drug-
flavonoid interactions should be considered before supplementing people who 
have medication [163]. Otherwise, the in vivo effects of flavonoids are generally 
considered as positive, and supplementation of foods with quercetin to reach 
the levels of 200 – 500 mg quercetin/day is suggested to be safe [79].  
Any undesired effects due to sea buckthorn interventions in clinical studies 
have been rare. Ten of the 30 healthy male participants recruited to the study 
of Eccleston et al. [53] dropped out because of gastro-intestinal upset and 
diarrhea during the intervention with sea buckthorn or placebo juice. The 
drop-outs were both from the sea buckthorn juice group and from the placebo 
juice group [53]. The acidity of the juices consumed at doses of 300 ml/day 
might have contributed to this side effect. Eccleston et al. also report an 
increase in fasting blood triacylglycerols during the intervention with sea 
buckthorn juice (300 ml/day for eight weeks). This effects, however, was not 
statistically significant. The authors suggest that the sugars of the juice may 
have contributed to this.  Johansson et al. [96] found that sea buckthorn seed 
and pulp oil at 5 g/day for four weeks induced a small (+0.3 mmol/l) but 
statistically significant rise in fasting blood glucose in healthy men. The rise 
was evident in the placebo group as well (+0.25 mmol/l) and was explained by 
increased fat intake during the study [96].  




Sea buckthorn flavonoids and alcohol extracts are among the berry fractions 
most intensively studied for their physiological effects (Table 11). The chemical 
composition of the fractions is reported in a minority of the articles only. 
Alcohol extracts most likely are enriched with flavonoids, other phenolics, 
sugars and vitamin C. It is probable that the composition of the flavonoid 
preparations is similar, since most authors do not specify whether the 
flavonoid fraction was purified to remove the other components. A few studies 
report using water extracts of berries or seeds. The phenolic content of the 
water extracts is lower compared to alcohol or alcohol-water extracts [69], but 
they likely are more abundant in the more polar components.  
In vitro and animal studies show that sea buckthorn berry flavonoids as well as 
alcohol and water extracts have strong antioxidant activity. This contributes to 
their potential to protect cells against cytotoxicity and modulate inflammation 
(Table 11). The dual effects of sea buckthorn flavonoids on inflammation have 
been reported. Mishra et al. [128] observed in vitro the proinflammatory effects 
by sea buckthorn flavonoids in human peripheral mononuclear cells. This may 
be a desirable effect in the defence against microbial infections. Others have 
reported reduced inflammation by sea buckthorn flavonoids, alcohol extracts 
and juice in vivo and in vitro [12, 13, 23, 89]. This effect can be considered 
positive, as low grade chronic inflammation contributes to the pathogenesis of 
several diseases. The effects of sea buckthorn flavonoids on the immune 
system, inflammation, and the functions of the endothelium, seem to be 
mediated at least in part by modulating the activation of transcription factor 
NF-kB and the expression of inflammatory genes [12, 13].  
In vitro studies and one animal study [151], respectively, suggest the inhibition 
of cancer cells and protection against induced tumorigenesis by sea buckthorn 
alcohol extracts (Table 11). In the animal study, the up-regulating effect of the 
fairly high dose of sea buckthorn alcoholic extract on the xenobiotic 
metabolizing enzymes was observed.  There are indications of wound healing 
promotion by topical sea buckthorn flavonoids in vivo [72], due to antioxidant 
activity and enhanced collagen production. A mice study suggests the 
protective effect of sea buckthorn flavonoids against thrombotic events [37]. 
Flavonoids from sea buckthorn seeds restricted the sucrose-induced 
hypertension in rats [152]. Water extract from sea buckthorn seeds had a 
hypoglyglycemic effect in diabetic rats [240]. 
Despite the promising results in vitro and in animals, a clinical study involving 
healthy men with slightly elevated blood cholesterol levels did not result in 
significant changes by sea buckthorn flavonols on plasma lipids, CRP or other 
markers of cardiovascular disease risk [201]. The intake of flavonols taken was 
fairly low, and the level of CRP, among others, was within the reference range 
at baseline.  
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The effects of sea buckthorn juice (Table 11) have been investigated in one 
clinical trial aiming to study the effects on the risk markers of cardiovascular 
disease [53]. No clear positive changes in the healthy men were observed, 
although there was a nonsignificant rise in plasma HDL and a nonsignificant 
small increase in the lag phase of LDL oxidation. As in the clinical flavonoid 
study [201], the number of participants was fairly low in the juice study as 
well, and prestudy power calculations were not presented. An animal study 
indicates the antioxidant activity of sea buckthorn juice against nicotine 
induced oxidative stress [199]. In vitro inhibition of cancer cells and the 
attenuation of inflammation by sea buckthorn juice has been reported [23]. 
Whereas the alcohol extracts are enriched with phenolics, sea buckthorn juice 
may additionally contain even up to >3% of oil [209], depending on the 
processing and origin of the berries.  
The effects of sea buckthorn oil, especially sea buckthorn seed oil, have been 
studied intensively (Table 11). A majority of the studies, where the method of 
extraction was specified used CO2-extracted oil. Compared to the hexane-
extracted oil the concentrations of tocols, carotenoids and phytosterols are 
higher in the oils extracted with supercritical CO2 [10]. In three clinical studies 
a combination of sea buckthorn seed and pulp oils have been used [96, 229].  
In animals, the positive effects of sea buckthorn oils against SO2-induced 
cytotoxicity and the detrimental effects of hypobaric hypoxia were observed 
[164, 181, 225]. Antioxidant activity most likely contributes to these effects. The 
beneficial effects of sea buckthorn seed oil in the treatment of wounds (a 
combination of oral and topical intake) were observed in a carefully conducted 
animal study [216]. In clinical investigations using doses several times lower, the 
positive effects of sea buckthorn on the skin and mucosa were shown [229, 231].  
The positive effects of sea buckthorn seed and pulp oils against gastric ulcers 
were observed in two animal studies [198, 227]. One thorough animal study 
[88] suggests the protective effects of sea buckthorn seed oil against 
hepatotoxicity using a fairly modest dose of 0.26 mg oil/kg body weight/day. 
Antioxidant action is likely an important mechanism in both of these effects.  
Concerning the effects of sea buckthorn oil on the risk factors of cardiovascular 
diseases and diabetes, several positive changes in lipid parameters were induced 
in rabbits [17]. In clinical studies, the inhibition of platelet aggregation and an 
increase in plasma HDL cholesterol levels have been observed with doses lower 
than those of the rabbit study [96, 231]. However, several parameters were also 
unaffected by sea buckthorn oils in the clinical studies by Yang et al. [231] and 
Johansson et al. [96]. In both studies the mean baseline levels of the measured 
risk markers were within or only slightly different from the reference values at 
baseline. A mild elevation of the serum glucose was observed in one study 
during the supplementation with sea buckthorn oil and placebo oil [96]. This 
was suggested to be because of increased fat intake during the study. 
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Table 11. Summary of studies investigating the physiological effects of sea buckthorn 




against toxic substances Alcohol extr. Flavonoids Water extr. Juice Seed oil Berry oil 
In vitro studies + +     
Animal studies +   + + + + 
Inflammation and immunomodulation
In vitro studies + + +     
Animal studies    + 
Clinical studies +/-    
Proliferation and apoptosis, mechanisms related to 
cancer     
In vitro studies   + 2 + +     
Animal studies +       
Antimicrobial properties
In vitro studies + + + 3     
Wounds, skin and mucosa
Animal studies + +   
Clinical studies   + 4 + 4 
Gastric ulcers 
Animal studies   + + 
Hepatotoxicity and liver fibrosis
Animal studies   +   
Clinical studies One clinical study reporting positive results. Berry fraction not specified.  
Endothelium 
In vitro studies +     
Clinical studies   +/-     
Platelet aggregation and thrombosis 
Animal studies +     
Clinical studies   +/- + 5 + 5 
Circulating lipids    
Animal studies   + (seed extr.) +   
Clinical studies +/- +/- +/- + & +/- 
Hypertension    
Animal studies + (seed extr.)     
Blood glucose, insulin sensitivity
Animal studies + (seed extr.) + (seed extr.)     
Clinical studies   mild- 5, 6 mild- 5, 6 
1 + = study/studies indicating positive effects by sea buckthorn; +/- = study/studies indicating no effects by 
sea buckthorn; - = study/studies indicating negative effects by sea buckthorn  
2 Positive effects also by ethanol acetate extract 
3 Whole berry powder 
4 Effect also by combined sea buckthorn seed and pulp oil 
5 Combined sea buckthorn seed and pulp oil 
6 Increase of blood glucose during both sea buckthorn oil and placebo oil interventions 
 
In conclusion, the potential of the flavonoid rich fractions of sea buckthorn to 
reduce oxidative stress, protect against cytotoxicity and modulate inflammation 
has been clearly shown in vitro. These mechanisms contribute to the beneficial 
effects observed in animal studies, regarding the risk factors of cardiovascular 
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diseases and protection against toxic subtances, among others. So far only a few 
fairly small clinical studies using sea buckthorn flavonoid rich fractions or juice 
have been carried out. Animal studies clearly show the antioxidant potential of 
sea buckthorn oils, and indicate anti-inflammatory and antioxidative effects. The 
benefits of sea buckthorn oils on wound healing, gastric ulcers and 
hepatotoxicity, shown in carefully conducted animal studies, deserve further 
investigation. The fairly few clinical studies conducted have found the beneficial 
effects of sea buckthorn oils on the skin and mucous membranes. The effects on 
the risk factors of cardiovascular diseases have been less consistent in humans, 
however. There is room for more, larger scale human investigations that 
concentrate on people having elevated levels of risk markers.   
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3 AIMS OF THE STUDIES 
The overall aim of the research project was to investigate the health effects of 
sea buckthorn berries and oil in humans. The project consists of two clinical 
trials with different target populations and aims, one focusing on the whole 
berries and one on the oil.  
The primary objective of the Clinical Trial 1 was to study the effects of sea 
buckthorn berries on the common cold, other infections, and on inflammation 
in healthy adults. It was hypothesized that the bioactive compounds of the 
berry may modulate immunity and reduce the risk of infections and duration 
of symptoms. The main outcome measures of the Clinical Trial 1 were the 
number and duration of common cold cases. The second aim was to 
investigate the effects of the berries on the circulating lipid markers associated 
with the risk of cardiovascular diseases, and on circulating flavonols, expected 
to be among the berry compounds affecting in humans.  
The primary objective of the Clinical Trial 2 was to study the effects of sea 
buckthorn oil on dry eye and the possible mechanisms of effect. The 
hypothesis was that the antioxidant and anti-inflammatory compounds of 
combined sea buckthorn seed and pulp oil would beneficially affect the 
symptoms and clinical markers of dry eye. The main outcome measures were 
tear film osmolarity, tear film break-up time, tear secretion, and dry eye 
symptoms evaluated using a dry eye symptom questionnaire. The second 
objective was to investigate the effects of sea buckthorn oil on circulating 
inflammatory markers and aminotransferases associated with the risk of 
cardiovascular diseases and type 2 diabetes.  
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4 PARTICIPANTS, MATERIALS AND METHODS 
4.1 CLINICAL TRIAL 1: EFFECTS OF SEA BUCKTHORN BERRIES ON 
INFECTIONS AND INFLAMMATION (I), AND ON CIRCULATING 
LIPID MARKERS AND FLAVONOLS (II)  
4.1.1 Study design and participants (I-II) 
The study was of double-blind, randomized, parallel design. The study 
protocol was supported by the by the Ethics Committee of the Hospital District 
of Southwest Finland. A total of 254 women and men of 19 to 50 years of age 
were included, after their informed written consent to the study procedures. 
Half of the participants were randomized to receive sea buckthorn and half to 
receive a placebo. Exclusion criteria were: 1) a chronic disease, 2) continuous 
medication affecting the immune system, 3) a body mass index of less than 18 
or more than 30 kg/m2, 4) an influenza vaccination taken during the last 6 
months, 5) unwillingness to restrict the use of nutrient supplements, sea 
buckthorn products and certain probiotic products during the trial, and 6) if it 
was not possible for the candidate to store the study product as intended. 
The intervention lasted for three months during a period from January 2005 to 
May 2005. During this time, the participants daily consumed 28 g of sea 
buckthorn or a placebo puree, and kept a logbook record concerning their 
symptoms of common cold, digestive tract infections and urinary tract 
infections. Questions concerning the compliance of the trial protocol and the 
medication used were answered each day as well. The participants were asked 
to give a nasal swab and blood samples when they felt they had a case of the 
common cold. In addition, a study visit at the beginning and end of the 
intervention was scheduled for the collection of blood samples and 
background information. 
4.1.2 Study products (I-II) 
The sea buckthorn product was a frozen puree of Hippophaë rhamnoides ssp. 
mongolica cv. Prozcharachnya berries. Also the seeds of the berries had been 
ground to facilitate the absorption of the seed components in the digestive 
system. In addition to the berries (96% w/w) the puree contained a sweetener 
solution and other additives. The placebo puree was similar in appearance, 
taste and smell and consisted of water, fructose, bread crumbs and additives. 
The participants were allowed to take the puree any time of the day, with or 
away from a meal, as a single or divided dose.  
The daily dose of sea buckthorn puree contained 16.7 mg flavonol glycosides, 
approximately 9.0 mg/day calculated as aglycones. Glycosides of isorhamnetin 
were the most abundant. The flavonol glycosides as mg/28 g of puree were: 
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isorhamnetin 3-O-glucoside-7-O-rhamnoside 5.8  0.7, quercetin 3-O-
rutinoside 1.5  0.9, quercetin 3-O-glucoside 1.6  0.4, isorhamnetin 3-O-
rutinoside 5.1  0.8, isorhamnetin 3-O-glucoside 2.4  0.4 and kaempferol 3-O-
rutinoside 0.3  0.4 (tentative identification).  
The flavonol glycosides and vitamin C content of the sea buckthorn puree 
were analyzed using HPLC-UV methods [99, 209, 238]. The vitamin E content 
was analyzed with a HPLC-fluorescence method [102]. The oil content was 
measured gravimetrically [209]. The fatty acids were analyzed as methyl esters 
[4] by gas chromatography [231]. 
4.1.3 Number and duration of the common cold and other infections (I) 
The analysis of infections was based on the self-assessment of the participants. 
In the symptom logbooks, typical symptoms of the common cold, digestive 
tract infections and urinary tract infections were listed, with a severity scale 
from 0 = none to 3 = severe symptoms. The participants were asked to report a 
symptom only if it, in their assessment, was caused by an infection. A 
participant was considered to have a case of the common cold/digestive tract 
or urinary tract infection if he/she reported at least one symptom at a severity 
of  1 for at least one day. For the duration of the infection, each day with  1 
symptoms was included. The symptom logbook was not validated. 
4.1.4 C-reactive protein (I), lipid markers and flavonols (II)   
A blood sample after a 12 h fast was taken at the beginning and end of the 
intervention for the analyses of CRP, lipid markers and flavonols.  
Serum CRP concentrations were measured with a high sensitivity particle-
enhanced immunoturbidometric assay using Roche tina-quant reagents (Roche 
Diagnostics, GmbH, Mannheim, Germany) and a fully automated analyzer 
Roche Modular P800 (Roche Diagnostics, GmbH, Mannheim, Germany). The 
serum total and HDL cholesterol, and triacylglycerol concentrations were 
measured by standard enzymatic methods using Roche Diagnostics reagents 
(Roche Diagnostics, GmbH, Mannheim, Germany) with a fully automated 
analyzer Roche Modular P800 (Roche Diagnostics, GmbH, Mannheim, 
Germany). All of the above-mentioned analyses were carried out at TYKSLAB 
(Turku, Finland). The LDL cholesterol was calculated using the Friedewald 
formula [57].  
The concentrations of flavonols quercetin, kaempferol and isorhamnetin in the 
plasma were analysed using an HPLC fluorescence method [54, 201] after an 
enzymatic hydrolysis of flavonol conjugates to their aglycones [85, 201]. The 
Helix pomatia preparation (β-glucuronidase, type HP-2, Sigma, Saint Louis, 
MO, USA) used for the hydrolyses was contaminated with flavonols [33] and 
therefore purified using active charcoal prior to the analyses [124]. For 
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quantitative analysis internal standard rhamnetin (Extrasynthese, Genay, 
France) was added to each sample. 
4.1.5 Statistical analyses (I-II) 
The sample size for the study was estimated according to the assumed number 
and duration of common cold cases. Fifty percent of the participants in the 
placebo group were assumed to have one case of the common cold during the 
study [80]. With a sample size of 120 participants per group, the study would 
have a power of 85% to detect a difference of 20 percentage units in the 
incidence of cases between the treatment groups if a 2 test was used (two-
sided tests, 0.05 significance level, 10% assumed drop-out rate). If the 
symptoms lasted for 5 - 7 days [16], a difference of two days in the common 
cold duration would be detected with a sample size of 130 participants per 
group (standard deviation = 5 days, power ≈ 85%, two-sided tests, 0.05 
significance level, 10% drop-out).  
The statistical analyses of the logbook data were carried out using generalized 
linear models (SAS software, version 9.1.3 SP2, GENMOD procedure; SAS 
Institute Inc., NC). In all statistical models, a logarithmic link function was 
used to convert the estimates of the parameters into relative risks (RR; 
unadjusted, no covariates were used). The estimated RR for infections or the 
duration of symptoms were calculated always comparing the sea buckthorn 
group to the placebo group, i.e. RR significantly less than 1 would denote a 
beneficial effect of sea buckthorn. The values of the symptom duration were 
distributed abnormally. Accordingly, data concerning duration is expressed as 
median (range).  
Due to the abnormal distribution of the CRP and flavonol data, they were 
analysed using rank analysis of covariance with the baseline measurement as a 
covariate (SAS software, version 9.1.3 SP2, SAS Institute Inc., NC). Data on the 
CRP and flavonol concentrations are expressed as median (range) and median 
(quartiles), respectively. To minimize the interference of acute infections on the 
CRP results, additional analyses excluding the participants with CRP values ≥ 
10 mg/l [154] were carried out. The analyses of total, HDL and LDL cholesterol 
and triacylglycerols were carried out using linear models (MIXED procedure, 
adjusted for baseline concentration and other covariates). Fisher's exact test 
was used to compare the number of common cold samples taken in treatment 
groups (same software as above).  
Two sets of analyses were always performed: one including all randomized 
participants (compliant and noncompliant), and one including only the 
compliant participants. Unless otherwise noted, the presented results concern 
the analyses of all participants. Two-sided significance tests and significance 
levels of 0.05 were used throughout.  
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4.2 CLINICAL TRIAL 2: EFFECTS OF SEA BUCKTHORN OIL ON DRY 
EYE (III-IV) AND ON CIRCULATING AMINOTRANSFERASES AND 
BIOMARKERS OF INFLAMMATION (V) 
4.2.1 Study design and participants (III-V) 
A total of 100 women and men between 20 to 75 years of age were randomized 
to this double-blind, placebo-controlled, parallel trial. They gave their written 
informed consent to the study procedures, which were approved by the Ethics 
Committee of the Hospital District of Southwest Finland. The inclusion 
criterion was an experience of dry eye symptoms. The exclusion criteria were 
severe illness, pregnancy or breastfeeding, smoking, and regular use of 
strongly anticholinergic drugs. Fifty-two participants were randomized to the 
sea buckthorn group and 48 the placebo group. Eighty-six participants 
completed the study.  
The intervention period lasted for three months from autumn 2008 to winter 
2009. During this period the participants consumed 2 g of sea buckthorn or 
placebo oil daily in the form of 2 capsules twice/day with a meal. The 
participants attended a study visit at the beginning of the intervention, after 
one month, and at three months when the intervention ended. In addition, a 
post-check one to two months after taking the last study capsules was 
scheduled.  
4.2.2 Study products (III-V) 
The sea buckthorn capsules contained both sea buckthorn berry and seed oil. 
The combined oil was manufactured by Aromtech Ltd (Tornio, Finland) using 
supercritical carbon dioxide extraction. The most abundant fatty acids in the 
oil were: 16:1n-7 (346 ± 48 mg/daily dose of 2 g), 16:0 (338 ± 47 mg), 18:2n-6 (245 
± 34 mg), 18:3n-3 (149 ± 21 mg), 18:1n-9 (316 ± 45 mg), and 18:1n-7 (108 ± 15 
mg). The - and -tocopherol contents were 6.0 ± 0.4 mg/2 g and 0.8 ± 0.1 mg/2 
g, respectively. The total carotenoid content was 1.8 ± 0.4 mg/2 g oil. The 
placebo oil consisted of triacylglycerols of medium-chain fatty acids isolated 
from coconut and palm kernels: 8:0 (884 ± 11 mg in the daily dose), 10:0 (733 ± 
4 mg), 12:0 (1 ± 0 mg), and 14:0 (2 ± 0 mg). The placebo oil contained neither 
carotenoids nor γ-tocopherol, and only 0.2 ± 0.0 mg -tocopherol per 2 g of oil. 
The fatty acids were analysed as methyl esters by gas chromatography [4, 232]. 
Tocopherols and carotenoids were analyzed using HPLC-UV/Visible methods.  
4.2.3 Clinical tests and symptoms of dry eye (III) 
At each study visit several dry eye tests were performed. The tear film 
osmolarity (mOsm/l) was measured using an electrochemical osmolarity meter 
(Tearlab, Ocusense Inc., San Diego, CA). The stability of the tear film was 
measured as tear film break-up time (TBUT: seconds until breakup of 
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fluorescein tear film). Tear secretion was analyzed using the Schirmer test 
without anesthesia (length of wetting the Schirmer paper after 5 min).  
During the intervention period the participants daily kept a logbook record on 
their dry eye symptoms. In the logbook, typical symptoms were listed and the 
participants were asked to estimate the severity of each symptom using a 4-
point scale from 0 = none to 3 = severe. In addition, they were asked to record 
whether they had taken the study capsules, worn contact lenses, or used eye 
drops or other treatments for dry eye symptoms. At each study visit the 
symptoms were evaluated using a modified version of the validated dry eye 
symptom questionnaire the Ocular Surface Disease Index (mOSDI) [150, 185]. 
The symptom logbook and the mOSDI questionnaire were not validated.  
4.2.4 Fatty acids of the tear film (IV) 
To investigate the potential mechanisms of the effect of oil on dry eye, the fatty 
acid composition of the participants’ tear film was analysed. Samples for the 
fatty acid analyses were collected at each study visit using a Schirmer paper (5 
min tear flow from both eyes). Precautions were taken not to contaminate the 
sample with lipids from other sources. Participants’ tear film fatty acids were 
analyzed using the in situ boron trifluoride methylation and gas 
chromatographic method described by Joffre et al. [95] with some minor 
modifications. The fatty acid methyl esters were analyzed using a Perkin-
Elmer AutoSystem gas chromatograph (Norwalk, CT) equipped with a flame 
ionization detector (FID), and DB-1 capillary column (30 m × 0.25 mm i.d. × 
0.25 μm film thickness, Agilent Technologies Inc., Folsom, CA). To confirm the 
peak identities, some samples were also analysed by gas chromatography mass 
spectrometry (Shimadzu GC-MS QP5000 instrument, Shimadzu, Kyoto, Japan; 
DB-1 capillary column identical to that used with FID).  
The identification of most fatty acids was based on comparisons of the 
retention times and mass spectra of sample analytes to those of commercial 
reference compounds. According to mass spectra [comparisons to the Wiley 
mass spectral database (Shimadzu, Kyoto, Japan)] and retention times relative 
to the known peaks, five compounds for which a reference standard could not 
be found, were tentatively identified. The Schirmer paper was found to contain 
fatty acids that were also present in the tear samples. However, for most 
compounds the amounts were small compared to those in the tear samples. 
The paper also contained an unidentified peak that was not found in the tear 
samples. The area of this peak was used to calculate a correction factor 
allowing us to deduct the effect of the Schirmer paper from the tear sample 
analyses. As the proportions of the blank Schirmer paper gas chromatographic 
signals were not entirely constant from paper to paper this produced extra 
variation in the results.  
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4.2.5 Inflammatory markers and aminotransferases (V) 
Relating to the risk of cardiovascular diseases and type 2 diabetes, the 
circulating levels of inflammatory markers and aminotransferases were 
analysed. At each study visit, blood samples were taken from the participants 
for the analyses of inflammatory cytokines IL-6 and TNF-, CRP, and ALAT, 
ASAT and γ-glutamyl aminotransferase (GT). ALAT, ASAT and GT in lithium 
heparin plasma were analysed with photometric methods on a Modular P800 
automatic analyzer (Roche Diagnostics GmbH, Mannheim, Germany). CRP in 
serum was analyzed with an immunonephelometric assay on a Siemens Dade 
Behring BN II Nephelometer analyzer (Siemens Healthcare Diagnostics, Inc., 
Siemens Aktiengesellschaft, Munich, Germany). These analyses were carried out 
by TYKSLAB, Turku Finland. TNF-α and IL-6 were analysed simultaneously 
from serum samples with a Milliplex Human Serum Adipokine Panel B kit 
(Millipore, Billerica, MA, Usa) according to the manufactures instructions, using 
the Bio-Rad Bio-Plex 200 System (Espoo, Finland). 
4.2.6 Statistical analyses (III-V) 
The sample size was estimated prior to the study for observing a mean 
difference of  4 points in the mOSDI scores between the treatment groups. 
With a sample size of 37 participants/group the trial would have a power of  
80% to detect this difference at the end of the intervention (assumed standard 
deviation = 6 points, two-sided tests, 0.05 significance level). The drop-out rate 
was assumed to be 25% or less. Accordingly, a total of 100 participants were 
recruited.  
For the clinical tests of dry eye and mOSDI, changes from baseline values were 
used as dependent variables in the statistical analyses. The variables of change 
were analysed with a two-way analysis of variance (ANOVA) with a repeated 
measure term included in the model (SAS MIXED procedure). Baseline values 
of clinical tests and mOSDI, age, contact lens wear and sex were considered as 
potential covariates in the model. Only significant covariates (P < 0.05) and 
those with significant interactions with other variables in the model (P < 0.05) 
were included in the final model. The group-change interaction was included 
in order to calculate the estimates of changes. The results were adjusted for 
multiplicity using Bonferroni correction. Values in the text are means ± 
standard deviation. 
For each individual symptom in the logbook, the proportion of days with dry 
eye symptoms was calculated (number of days when the participant had the 
particular symptom/number of intervention days). This symptom day ratio 
was also calculated for overall non-specified eye symptoms. The symptom 
sum was calculated by summing the daily intervention period intensity scores. 
The proportions of participants having a symptom score of 0, 1, 2, or 3 as their 
maximum symptom in each group was calculated and the differences between 
the groups were tested using the Cochran-Mantel-Hanzel test. The differences 
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the between groups of ratio and the sum of symptom days were estimated 
from an ANOVA model and from an analysis of covariance model (ANCOVA) 
using the SAS MIXED procedure. Age and use of contact lenses were 
introduced as covariates in the ANCOVA model. In addition, the symptom 
day ratio and symptom sum analyses were carried out separately for 
subgroups of participants above and below 45 years of age, and for contact 
lens wearers and those not wearing contact lenses. The logbook analyses were 
carried out by Statfinn Ltd (Turku, Finland). Values in the text are mean  
standard deviation or n (%) (maximum symptoms). 
The proportions of fatty acids were used as dependent variables in the 
statistical analyses of the tear film fatty acids. Variables of change were 
analyzed with a general linear model with repeated measures term included 
(SAS MIXED procedure). The baseline proportion of the fatty acid in question, 
age, contact lens wear, gender and baseline clinical dry eye test results (tear 
film osmolarity, tear film break-up time and Schirmer test) were considered as 
potential covariates in the model. Only significant covariates (P < 0.05) and 
those with significant interactions with other parameters in the model (P < 
0.05) were included in the final statistical model. The results were adjusted for 
multiplicity using the Bonferroni correction. The values in the text are mean  
standard deviation. 
Due to the abnormal distribution of aminotransferase activities and 
inflammatory marker concentrations, they are expressed as median (quartiles). 
The values at the end of the intervention (three months) of the sea buckthorn 
and placebo groups were compared using a rank analysis of covariate with the 
baseline measurement as a covariate using SAS software version 9.2 (SAS 
Institute Inc., NC). For the analyses of inflammatory markers, participants 
having CRP values above 10 mg/l, indicating acute infection or inflammation 
[154] were excluded from the statistical analyses to minimize the effect of acute 
infections on the results of the group comparisons.   
The primary data analyses were done including all randomized participants 
(compliant and noncompliant). Unless otherwise noted, the presented results 
concern these analyses. In addition, analyses including only participants who 
consumed the study capsules for at least 80% of the days during the 
intervention period (compliant participants) were conducted. Two-sided tests, 
significance levels of 0.05 and SAS software version 9.2 (SAS Institute Inc., NC) 
were used throughout.  
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5 RESULTS AND DISCUSSION 
5.1 EFFECTS OF SEA BUCKTHORN BERRIES ON INFECTIONS AND 
INFLAMMATION (I)  
5.1.1 Common cold and other infections (I) 
Sea buckthorn did not affect the risk [RR = 1.15, 95% confidence interval (CI) = 
0.90 - 1.48] or duration (RR = 1.05, 95% CI = 0.87 – 1.27) of common cold 
infections. Neither were there effects on digestive tract infections: RR (95% CI) 
for the number and duration of infections, respectively, were 1.06 (0.67 – 1.68) 
and 1.08 (0.82 – 1.43). The number of reported urinary tract infections was 
small (6 cases in the sea buckthorn group, 7 cases in the placebo group), and 
therefore the results can be considered as indicative at the most. The groups 
did not differ when all participants were included in the analyses. When only 
the compliant participants were included, the statistical analyses suggested a 
significant difference for the number of urinary tract infections (RR = 0.43, 95% 
CI 0.20 – 0.94) but not for the duration (RR = 0.60, 95% CI 0.28 – 1.29).  
The reasonably low dose of sea buckthorn berries realistic for long term 
everyday consumption was chosen for this trial. It approximates the dosage of 
dried berries (3 - 9 g) prescribed in the Chinese Pharmacopeia [39]. Compared 
to the recommended or reported average daily intakes, flavonols 
(approximately 9 mg/day calculated as aglycones) were the most affected of 
the potentially beneficial compounds. The estimated average Finnish daily 
intake of flavonols as aglycones is 5.4 mg [149], which is reasonably low 
compared to other Western countries [122].  The vitamin C content of the 
product was 15.6 mg/day which is about 21% of the recommended daily 
intake, and 13-17% of the average intake for adults in Finland [55, 153]. The 
amount of α-tocopherol in the daily dose was about 11-14% of the 
recommended daily intake and 11-15 % of the average reported real intake in 
Finland [55, 153]. The amount of ß-carotene in the daily dose equates to 31 
retinol equivalents, which is only 3 - 4% of both the recommended and average 
daily intake of Finns [55, 153]. The amount of oil of in the product was only 
about 1 g/day. The amounts of the above-mentioned biologically active 
compounds and oil in the study puree were within the range reported in sea 
buckthorn berries in earlier studies, but far from the highest levels observed 
[174, 209, 235, 238]. 
As flavonoids were among the compounds most affected by the intervention it 
was expected that they would have an effect. In addition, as the whole berry 
was used, synergistic activity of the compounds was expected [126]. In vitro 
and animal models have shown the antiviral effects of several flavonoids, 
flavonols among them, against a wide range of viruses [134]. The viruses 
affected by flavonoids include influenza A virus [40], and picornaviruses [43, 
91] that typically cause the common cold. In a cohort study, an inverse 
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association between the consumption of wine, especially red wine known to be 
rich in flavonoids, and risk of the common cold was observed [205]. Extracts of 
Echinacea plant, containing flavonoids among others, are widely used for 
treating and preventing respiratory tract infections. According to a meta-
analysis, some Echinacea herb preparations might be effective in shortening 
the duration and reliving the symptoms of the common cold [116].  
Ascorbic acid and dehydroascorbic acid exhibit antiviral activity against 
several viruses with different structures and replication strategies [58]. The 
effects of vitamin C on the common cold have been extensively studied. 
According to a large review concerning interventions with vitamin C in doses 
of  200 mg/day, vitamin C supplementation does not affect the risk of 
catching a common cold in the general population. However, in the subgroup 
of people under heavy physical stress, vitamin C reduced the incidence of the 
common cold [81]. Prophylactic consumption of vitamin C had a significant 
beneficial effect on the duration and severity of the common cold. However, 
the practical significance of this result was questioned. If taken after the onset 
of symptoms, the pooled estimates of the trials did not show significant 
benefits on the duration or the severity of symptoms [81]. 
Like for vitamin C, results concerning the effect of vitamin E on the common 
cold have been inconsistent. The protective effect in nursing home residents 
(200 IU/day for one year) [125] and in older men (50 mg/day for 4 years) [83] 
have been detected. However, also the negative effects of vitamin E on the 
common cold among older people have been reported [82, 84], and the effect is 
modified by smoking status and dwelling place [82, 83, 84]. In the same cohort 
of the Alpha-Tocopherol Beta-Carotene study, where the effects of vitamin E 
were investigated, -carotene supplementation had no effect on the common 
cold [83], but an interaction between vitamin E and -carotene 
supplementation was detected [82]. The participants in the current study were 
healthy adults, who exercised moderately and very few smoked. On the 
grounds of their eating habit information, it is likely that the participants 
obtained at least reasonable intakes of flavonoids and vitamins in their normal 
diet.  
As discussed in the literature review, the antibacterial properties of phenolic 
berry extracts, including sea buckthorn berry, have been reported in vitro [166]. 
Sea buckthorn berry extract was among the weakest inhibitors, but it still 
exhibited activity against the gram-negative bacteria tested, including the 
pathogenic species [166]. Cranberry juice has well-documented beneficial 
effects on urinary tract infections [93, 169].  Consuming juices in general, 
especially those made of berries is inversely associated with the risk of 
recurrence of urinary tract infection [106]. The effect of cranberry is thought to 
take place by two possible mechanisms: its components prevent the adhesion 
of the uropathogenic Escherichia coli bacteria to the uroepithelial cells, and/or it 
may affect the intestinal bacteria and promote those strains that are less 
adherent [93, 169]. Fructose and A-type proanthocyanidins, unique to the 
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Vaccinium berries are the components that prevent the E. coli adhesins 
necessary for its adhesion to the receptors of the uroepithelial cells [87, 169]. A 
mild activity of certain B-type proanthycyanidins was detected in vitro, but not 
in vivo [87].  
In this study, the definition of infections was based on self-assessment by the 
participants, a method that is frequently used in common cold studies [25, 111, 
213]. The clinical diagnosis of the common cold is in most cases simple, and 
can reliably be made by adult patients themselves [80]. The common cold can 
be considered in large part subjective [76], since even with modern diagnostic 
methods 20 - 30 % of cold cases remain without a proven viral cause [80]. 
Randomization was used to distribute the bias and noise potentially 
introduced by self-assessment of symptoms equally between groups. 
Regardless, they still interfere with the detection of a true signal [76]. The same 
applies for the urinary tract infections and digestive tract infections. The 
recommended practice for the diagnosis of urinary tract infections in Finland 
states that only the non-complicated cystitis in women can be diagnosed based 
on symptoms, without bacterial culture analyses from the urine [202]. The 
small number of reported urinary tract infections during the study has to be 
taken into consideration as well. Therefore, the results concerning this 
infection type are indicative only.   
5.1.2 Concentrations of C-reactive protein (I) 
There was a small but significant reduction of serum CRP levels in the sea 
buckthorn group compared to the placebo (P = 0.04) during the intervention. 
This reduction was evident also when only the compliant participants were 
included (P = 0.03), and when the ≥10 mg/l values were excluded (all 
participants P = 0.049, compliant participants P = 0.02). 
The acute-phase response is a non-specific systemic response of endothermic 
animals to most forms of tissue damage, infection, inflammation, and 
malignant tumours. It is characterized by fever, somnolence and metabolic 
alterations. In acute-phase response, the synthesis of so-called acute-phase 
proteins, including CRP, is rapidly up-regulated. The synthesis mainly takes 
place in the liver and is induced by cytokines originating at the site of the local 
detrimental events [157, 190]. All the biological functions of CRP are not fully 
understood [157]. It is known to bind to phospholipid constituents of damaged 
cells and microbes and to native and modified plasma lipoproteins. It activates 
the complement and induces inflammatory cytokines [157, 190]. CRP 
concentration in general population is stable. It reflects ongoing inflammation 
and tissue damage accurately compared to most other analysable markers 
[157]. 
CRP is considered an independent predictor of increased coronary risk. Its 
levels are increased in type 2 diabetes. The proinflammatory state contributes 
to the pathogenesis of both cardiovascular disease and type 2 diabetes that 
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often develop side by side [154, 157, 161, 170, 171, 172, 189]. Serum values  10 
mg/l are considered to reflect an acute ongoing infection or inflammation. 
From the cardiovascular health point-of-view, the cutpoints for the serum 
concentrations of CRP are: < 1 mg/l low risk, 1 - 3 mg/l average risk and >3 
mg/l high risk [154]. It is possible that CRP is not just a marker of risk, but 
contributes to the pathogenesis of cardiovascular diseases by exacerbating 
inflammation and tissue damage. However, the question of the possible causal 
link is still under investigation [46, 157].  
An inverse association between diets rich in plant based food and circulating 
concentrations of markers of inflammation, including CRP, has been reported  
[137, 222]. Oliveira et al. [146] found a negative association between blood CRP 
and the intake of fruits, vegetables, vitamin C, vitamin E and fibre in men only. 
Interventions with a 1000 mg/day dose of vitamin C for 2 months reduced CRP 
levels among healthy non-smokers, who had baseline levels indicating 
elevated cardiovascular risk (1 mg/l), but not in those with low baseline levels 
[22]. In the same trial, vitamin E (800 IU/day) had no effects. Wu et al. [226] 
found vitamin E supplementation (500 mg/day for 6 weeks) ineffective for 
reducing CRP in patients with type 2 diabetes. Of the carotenoids -carotene 
seems to be negatively associated with CRP in middle-aged and older women 
[221].  
As discussed in the literature review, anti-inflammatory actions of flavonoids 
and sea buckthorn flavonoid rich fractions have been well-documented in vitro. 
In U.S. adults, the levels of serum CRP were inversely associated with dietary 
flavonoid intake [143]. Both positive and inconclusive results have been 
reported from flavonoid interventions. A blackcurrant and orange juice 
supplementation (250 ml + 250 ml/day for 28 days) decreased serum CRP in 
patients with peripheral arterial disease [45]. Anthocyanins from elderberry 
(500 mg/day for 12 weeks) did not affect serum CRP or other markers of 
inflammation in postmenopausal women. No effects were observed on the 
markers of liver or kidney functions either [44].  
5.2 EFFECTS OF SEA BUCKTHORN BERRIES ON CIRCULATING LIPID 
MARKERS AND FLAVONOLS (II)  
5.2.1 Total, HDL and LDL cholesterol and triacylglycerols (II) 
An increased serum total or LDL cholesterol and triacylglycerols, and 
decreased HDL cholesterol are risk factors for cardiovascular diseases [68]. The 
current guidelines on cardiovascular disease prevention in clinical practice 
recommend target values of fasting total cholesterol <5 mmol/l and LDL 
cholesterol <3 mmol/l in people having only few other risk factors for 
cardiovascular diseases. For those at high risk, the target values are lower. No 
specific targets for HDL cholesterol or triacylglycerols are given, but it is 
pointed out that HDL cholesterol <1 mmol/l in men and <1.2 mmol/l in women 
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and fasting triacylglycerols >1.7 mmol/l are markers of increased risk [68]. In 
this study the intake of sea buckthorn berries did not affect the levels of total, 
HDL, and LDL cholesterol or triacylglycerols in circulation.  
An inverse association between the intake of quercetin and circulating total 
and LDL cholesterol levels in Japanese women has been reported [8]. Oral 
quercetin lowered the serum cholesterol and phospholipids in mice, and had a 
nonsignificant reducing effect on the serum triacylglycerols. Quercetin reduced 
the activity and mRNA levels of enzymes involved in the hepatic fatty acid 
synthesis, suggesting the inhibitory effects on lipogenesis [144]. Of the 
flavonoids typical for sea buckthorn, kaempferol inhibited cholesterol 
biosynthesis in hepatic cancer cells (HepG2) and in breast cancer cells (MCF-7) 
[103]. In rats fed with cholesterol rich diet, oral isorhamnetin and quercetin 
decreased the serum total cholesterol. In rats getting a cholesterol-free diet, the 
total serum cholesterol tended to be lowered by isorhamnetin, but the effect 
was not significant. In rats getting the cholesterol-free diet the level of serum 
triacylglycerols in the quercetin group was significantly higher compared to 
the control. Isorhamnetin and quercetin had a lowering effect on the liver total 
cholesterol, and isorhamnetin reduced the liver triacylglycerols [90].  
The amounts of flavonols used in the above mentioned trials were higher 
compared to those in the daily sea buckthorn dose of our study. As reviewed 
in the literature part of the thesis (Chapter 2.2.8.3) the clinical sea buckthorn 
juice and flavonol interventions have not been beneficial in reducing the 
circulating cholesterol or triacylglycerol levels, whereas more positive results 
have been observed for sea buckthorn oil and in animal trials.  
5.2.2 Quercetin, kaempferol, isorhamnetin and their correlation with CRP 
(II) 
Consuming a low dose of sea buckthorn berries significantly increased the 
plasma concentrations of quercetin (P = 0.03) and isorhamnetin (P <0.01) 
compared to the placebo. There was a trend towards higher kampferol levels 
as well, but the effect was not significant (P = 0.07). The changes in flavonols 
did not correlate with the changes in CRP.  
Sea buckthorn berry is among the richest sources of isorhamnetin (mostly 
present as glycosides) in foodstuffs [167, 214, 238] (Chapter 2.1.1). Though 
isorhamnetin in large concentrations is not very common in foods, part of the 
dietary quercetin can be methylated in the liver to form isorhamnetin [121, 
133]. Methylation is extensive in rats [130], but likely of less importance in 
humans [121]. The methylation rate is affected by other components of the diet 
[49].  
The fact that there was no association between the plasma flavonols and CRP 
indicates that the sea buckthorn effect on CRP was probably caused by a 
synergy of several compounds, instead of being due to the flavonols alone. A 
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large proportion of sea buckthorn berry flavonoids are proanthyanidins, which 
were not analysed in this study. As reviewed in the first part of the thesis, they 
and several other components of sea buckthorn berry have been suggested to 
have immunomodulatory effects. 
5.3 EFFECTS OF SEA BUCKTHORN OIL ON DRY EYE AND POTENTIAL 
MECHANISMS OF EFFECT (III-V) 
5.3.1 Clinical tests and symptoms of dry eye (III) 
There was an increase in the tear film osmolarity from baseline to the end of 
the intervention in both treatment groups. The increase was significantly less 
in the sea buckthorn group (all participants: P = 0.04; compliant participants: P 
= 0.02). Changes in TBUT, Schirmer or mOSDI did not differ between the 
groups.   
According to the symptom logbooks, the maximum intensities of redness were 
significantly lower in the sea buckthorn group as compared to the placebo 
when all participants were included (P = 0.04). Compared to the placebo the 
proportion of participants reporting the highest redness scores of 3 during the 
intervention was 6% in the sea buckthorn group and 36% in the placebo group. 
The difference between the groups was not significant when only the 
compliant participants were included (P = 0.11), even though the trend was the 
same. The maximum intensities of burning were significantly lower in the sea 
buckthorn group in the compliant participants (P = 0.04), where 12% of the 
participants in the sea buckthorn group and 32%, in the placebo group 
reported 3 as their highest symptom score. The group difference was not 
significant when all participants were included (P = 0.05), though again the 
trend was towards lower maximums in the sea buckthorn group.  
Other individual symptoms did not differ between the groups. There was a 
significant difference in the proportion of days recorded as overall eye 
symptom days, without specification of the symptom, in the subgroup of 
contact lens wearers. This proportion was smaller in the sea buckthorn group 
when all participants were included (P = 0.049) but not when only the 
compliant participants were included (P = 0.19).  
Previous studies indicate that oral intake of n-6 -linolenic acid alone, or in 
combination with linoleic acid, and/or n-3 fatty acids may be beneficial for dry 
eye [7, 14, 104, 119, 127]. The effects of fatty acids are likely to be mediated 
through alleviating the ocular inflammation contributing to dry eye and 
associated with both aqueous deficient and evaporative dry eye [1]. The 
positive effects n-6 fatty acids may be due to the increased production of anti-
inflammatory and tear production stimulating eicosanoid prostaglandin E1 
from dihomo--linolenic acid (20:3n-6) [7, 160]. Beneficial effects of 
antioxidants on dry eye have been reported as well [21]. This is likely to be due 
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to the reduction of oxidative damage, which may activate inflammation [21, 
156]. As the inclusion criterion in this trial was just the experience of dry eye 
symptoms, both dry eye types were represented. Based on the baseline values 
of the clinical tests, the dry eye of the participants was not very severe. The dry 
eye definition includes the aspect of symptoms of discomfort [1]. It is known 
that the association between dry eye symptoms and clinical dry eye tests is 
poor [138].  
Tear film hyperosmolarity is a focal factor in dry eye, and common to its 
different forms. Sea buckthorn oil attenuated the increase in osmolarity taking 
place during the cold season. From the start to the end of the intervention, the 
temperature in Turku dropped considerably contributing to low air humidity 
indoors and outdoors. Low relative humidity increases tear evaporation rate 
[215], and dry eye symptoms are more common during periods when indoor 
heating systems are used [132]. A positive effect of sea buckthorn oil on typical 
symptoms of dry eye, redness (all partipants) and burning (compliant 
participants), was observed as well. 
5.3.2 Fatty acids of the tear film (IV)  
Monounsaturated and saturated branched-chain iso- and anteiso-fatty acids 
were the most abundant fatty acids in the tear film, each constituting about or 
just below 40% of all fatty acids at baseline. The proportions of straight-chain 
saturated and polyunsaturated fatty acids accounted for ≈ 15% and ≈ 7% of the 
baseline fatty acids, respectively. The most abundant individual compounds 
were oleic, vaccenic and palmitic acids. Changes in the proportions of 
individual fatty acids or groups of fatty acids during the intervention did not 
differ between the sea buckthorn and placebo groups (branched-chain fatty 
acids P = 0.49, saturated P = 0.59, monounsaturated P = 0.53, polyunsaturated P 
= 0.16). 
Meibomian glands at the margins of the eyelids secrete meibum. Meibum 
lipids contribute to the lipids of the tear film and are essential for its normal 
function [27, 158]. Cholesteryl and wax esters are the main lipid classes of 
meibum, together in somewhat equal proportions representing about 60% of 
total lipids. Chain lengths of the fatty acid moieties in cholesteryl esters vary 
from 18 to over 30 carbons, most of them being monounsaturated or saturated. 
The most common wax ester fatty acids are 18:1, 18:2 and 18:0. Both cholesteryl 
and wax esters contain a large proportion of branched-chain fatty acids [26, 27, 
28, 29, 30, 139, 191]. Even though the amount of polar lipids is small compared 
to the non-polar lipids, they are thought to be essential as an amphiphilic sub-
layer between the aqueous tear film and the outermost non-polar lipid sub-
layer. Recently, Butovich et al. [30] identified very long chain (O-acyl)-ω-
hydroxy fatty acids in human meibum. They are negatively charged and are 
suggested to be the lipid group responsible for the amphiphilic sub-layer and 
possibly be affected in evaporative dry eye [27, 30]. 
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Meibomian gland dysfunction is a condition associated with evaporative dry 
eye and posterior blepharitis [1, 50]. The meibum lipids from meibomian gland 
dysfunction patients have a lower proportion of straight-chain saturated and a 
higher proportion of branched-chain saturated fatty acids compared to healthy 
people [95]. Blepharitis patients with ocular damage similar to that of dry eye 
had a lower proportion of phosphatidylethanolamine and sphingomyelin 
among meibum polar lipids compared to those blepharitis patients without 
dry eye signs [192]. Also the amount of carotenoids in meibum is reduced in 
meibomian gland dysfunction and older age [148]. The tear film lipid layer is 
thinner in people experiencing dry eye symptoms compared to those with no 
symptoms [20].  
De novo fatty acid synthesis in meibomian glands has been observed in animals 
[52, 105]. Results from a mouse feeding trial indicate that dietary intake is not the 
major source of the monounsaturated fatty acids of the eyelid lipids [129]. The 
effects of dietary n-3 and n-6 fatty acids on the fatty acids of the phospholipids in 
the lacrimal glands have been reported, however. These fatty acid changes were 
associated with the effects on inflammation and dry eye [219]. 
Only few human intervention trials investigating the effects of oil intake on the 
fatty acid composition of the meibum or tear film have been carried out. Only 
one [120], was found, stating that supplementation with 6 g/day flaxseed oil 
rich in n-3 fatty acids for one year in patients with meibomian gland 
dysfunction resulted in improvements of symptoms and some of the clinical 
parameters. A decrease in the proportion of saturated fatty acids in the 
meibum of the flaxseed group was also reported. However, it was unclear 
from the article whether the change was statistically significant. The fatty acid 
compositions or the changes were not presented. A case-study by Sullivan et 
al. [200] found differences in the meibum polar lipid profiles of Sjögren’s 
syndrome patients according to their n-3 fatty acid intake from their habitual 
diet. Sjögren’s syndrome is an autoimmune disease that is associated with an 
increased risk of dry eye [1].  
No effects on the fatty acid composition of the tear film were seen in this study. 
It is possible the benefits of sea buckthorn oil were mediated through effects on 
ocular inflammation. As the inclusion criterion in this trial was the experience 
of dry eye symptoms without further clinical tests, different dry eye types 
were represented. The meibum fatty acid composition of individuals with 
aqueous deficient dry eye is similar to that of healthy people [95]. Agonistic 
effects of sea buckthorn oil fatty acids on the peroxisome proliferator-activated 
receptor γ (PPARγ) may be possible [140]. PPARγ is a transcription factor 
regulating the lipid metabolism. It is activated by polyunsaturated fatty acids, 
including linoleic acid, which increases lipid production by sebaceous cells and 
is needed for their differentiation in vitro [179]. Nien et al. [140], based on their 
study on mice, suggests that PPAR ligands, including n-3 and n-6 fatty acids, 
may positively influence dry eye by stimulating meibocyte differentiation, and 
reducing inflammation and meibomian gland lymphatic infiltration. 
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5.4 EFFECTS OF SEA BUCKTHORN OIL ON INFLAMMATORY 
MARKERS AND AMINOTRANSFERASES (V) 
5.4.1 Concentrations of cytokines and C-reactive protein (V) 
The circulating concentrations of IL-6 and TNF- at baseline were not elevated 
as compared to the earlier trials [137, 173, 239], and the levels were not affected 
by supplementation with sea buckthorn oil (IL-6, P = 0.37; TNF-, P = 0.97). 
The median (quartiles) serum concentrations of CRP at baseline were low [154] 
in both groups [1.0 (0.4; 1.5) mg/l in the sea buckthorn group; 1.1 (0.5; 2.1) mg/l 
in the placebo group]. The sea buckthorn oil supplementation did not affect the 
levels (P = 0.97).  
Dry eye is associated with increased levels of IL-6 and/or TNF-α in tears [239]. 
However, the inflammatory markers in the blood are commonly not elevated 
[210, 239], with the exception of dry eye patients with Sjögren’s syndrome 
[239]. Also, the comparatively low baseline concentrations of the participants 
in our trial suggest that the inflammation associated with dry eye is local, and 
not reflected in the serum markers of inflammation.  
Production of CRP is stimulated by pro-inflammatory IL-6 and TNF-α, and all 
three inflammatory markers are associated with the risk of cardiovascular 
diseases [98, 154, 161, 170, 171, 172, 173, 189]. Consumption of whole sea 
buckthorn berries reduced the serum CRP in healthy adults in Clinical Trial 1. 
Even though the seeds of the sea buckthorn oil puree were crushed to make 
the seed oil available as well, the amount of oil in the daily dose of sea 
buckthorn in Trial 1 was only 1 g. Based on the results of Clinical Trial 2, it is 
likely that sea buckthorn oil, at least not alone, was not responsible for the 
observed decrease in CRP in Trial 1.  
5.4.2 Aminotransferases (V) 
Supplementation with sea buckthorn oil did not affect the activities of the 
plasma ALAT (P = 0.23), ASAT (P = 0.47) or GT (P = 0.21), the median levels of 
which were within the reference range throughout the study [182, 197]. 
Elevated activity of ALAT, ASAT and GT are indicators of liver diseases [41]. 
In a study concerning the US population, the elevation of aminotransferases 
could not, in most cases, be explained by alcohol consumption, viral infections 
or iron overload. Instead, the higher activities were associated with obesity and 
other risk factors of cardiovascular diseases and type 2 diabetes. This indicates 
they are markers of non-alcoholic fatty liver, the hepatic component of the 
metabolic syndrome [41]. Of the aminonotransferases ALAT has the strongest 
correlation with liver fat [223] and its increased concentration in the circulation 
is associated with a greater risk of type 2 diabetes and coronary heart disease 
events [41, 186, 187].  
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A one year supplementation with n-3 fatty acids (2g/day) reduced the serum 
levels of aminotransferases and TNF-, and improved the fatty liver in non-
alcoholic fatty liver patients [194]. Vitamin E supplementation (800 IU/day) of 
almost two years improved the histological features of non-alcoholic 
steatohepatitis and reduced the serum ALAT and ASAT values in humans 
[184]. Consuming berry meals equalling with 163 g of fresh northern berries 
per day for five months lowered the ALAT values of slightly overweight 
women [113]. An ethanol extract of sea buckthorn berries and oil with a 
composition similar to the one used in this trial, were among the meals of the 
berry group. Results suggesting the hepatoprotective effects of sea buckthorn 
seed oil and an undefined sea buckthorn extract have been published [60, 88] 
as described in more detail in the literature review of this thesis (Chapter 2.2.7, 
Table 8).  
Reductions of CRP concentrations and aminotransferase activities even within 
the current reference values are likely to be beneficial [38, 56, 67, 154, 172]. 
Despite the encouraging previous investigations, sea buckthorn oil was 
inefficient in this trial. In most previous trials indicating the beneficial effects of 
plant oils or sea buckthorn on aminotransferases and/or markers of 
inflammation, participants or animals susceptible to cardiovascular or liver 
diseases or type 2 diabetes have been used. Most often the doses have been 
higher as well.   
5.5 SUMMARY 
In the present study, the health effects of sea buckthorn berry and oil were 
investigated in two double-blind, placebo-controlled randomized clinical trials. 
The main interest of the berry trial was on infections and inflammation, 
whereas the oil trial concentrated on the dry eye effects. In addition, the effects 
on markers associated with cardiovascular and type 2 diabetes risk were 
investigated in both trials.  
In the berry trial, the study product was frozen sea buckthorn berry puree, 
where also the seeds of the berries were ground fine. The daily berry dose of 28 
g contained 1 g oil, mostly form the soft parts of the berry. Compared with the 
average daily intakes of Finns, the intervention had the greatest effects on the 
intake of flavonols (167% of the average daily intake in the daily dose of berry 
puree [149]) and vitamin C (13 - 17% of the average daily intake [153]), 
whereas the intake of lipophilic components was less affected.  
In the oil study, combined sea buckthorn seed and berry oil extracted using 
supercritical CO2 was used. The daily dose was 2 g in the form of four 
capsules. The α-tocopherol and α-linolenic acid contents in the daily dose of oil 
were 58 - 82% and 6-9%, respectively, of the average daily intakes of Finns 
[153]. The daily amounts of carotenoids were similar in the two study 
products: 1.7 mg/day in the berry puree and 1.8 mg/day in the oil. However, 
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the bioavailability of carotenoids may have been better from the oil because of 
higher rate of absorption [145, 180].  
In the berry trial, no effects on the risk or duration of the common cold or 
digestive tract infections were observed in healthy adults having healthy diets 
and lifestyles. Complementary statistical analyses suggested positive effects on 
urinary tract infections, but due to the small number of cases and the lack of 
confirmation of diagnosis by bacterial cultures, the results can be considered as 
indicative and hypothesis generating only. However, the low dose of only 28 
g/day for 3 months resulted in a small, but statistically significant reduction in 
the levels serum CRP. As CRP is a focal inflammatory marker associated with 
the increased risk of cardiovascular diseases and type 2 diabetes, this result is 
interesting.  
Consuming sea buckthorn berries increased the plasma concentrations of the 
flavonols isorhamnetin and quercetin, but did not affect the circulating total, 
LDL or HDL cholesterol or triacylglycerol levels in the participants, having 
baseline levels within the recommended range. The lack of correlation between 
plasma flavonols and CRP changes suggests that the CRP effects were not 
caused, at least solely, by the sea buckthorn flavonols, but more likely by the 
synergetic effects of different berry components.  
In the oil trial, sea buckthorn oil (2 g/day for 3 months) was found to attenuate 
the increase of tear film osmolarity taking place during the cold season when 
the air is dry indoors and outdoors. Also the maximum severity of typical dry 
eye symptoms of redness (significant when all participants were included) and 
burning (significant in compliant participants) were lower in the sea buckthorn 
group. In the subgroup of contact lens wearers the proportion of days with 
overall, non-specified eye symptoms was smaller compared to the placebo 
(significant when all participants were included).  
Oral intake of sea buckthorn oil did not affect the tear film fatty acid profile 
indicating the positive effects of the oil were not mediated by direct 
incorporation of fatty acids into the tear film. Involvement of also other 
compounds in the oil is likely, as an association between reduced meibum 
carotenoids and dry eye has been reported. The possible mechanisms of effect 
include modulation of the inflammatory reactions of dry eye and the effects on 
meibocyte differentiation or lipid excretion.  
Sea buckthorn oil did not affect the levels of circulating CRP, IL-6 and TNF- 
and aminotransferases, associated with the risk of cardiovascular diseases and 
diabetes in the participants having non-elevated median baseline levels. The 
lack of effect on the systemic markers of inflammation does not rule out the 
possibility of modulation of the local ocular inflammation associated with dry 
eye. Based on this, the decreasing effect of sea buckthorn berries on serum CRP 
was likely caused by the less lipophilic components of the berry, or their 





Animal and in vitro studies clearly show the antioxidant effects of sea 
buckthorn berry fractions. Antioxidant action and modulation of inflammation 
are thought to be focal in mediating the beneficial effects observed in animals: 
protection against cytotoxic agents (oils and polar fractions), tumorigenesis 
(alcohol extract), wound healing (oils and flavonoids), gastric ulcers (oils), 
hepatotoxicity (oils) and risk factors of cardiovascular diseases (oils and polar 
fractions). Only a few clinical studies concerning the health effects of sea 
buckthorn berries and oil have been conducted. The positive indications of sea 
buckthorn oils on the skin and mucosa have been observed in humans. Clinical 
study observations on the prevention of platelet aggregation and the elevation 
of blood HDL cholesterol due to sea buckthorn oils have been published.  
In the clinical studies of this thesis, the physiological effects of sea buckthorn 
berries and oil were investigated. It was observed that a modest intake of 28 g 
of sea buckthorn berry puree/day for 3 months mildly, but significantly 
reduced the serum levels of the inflammatory marker CRP in healthy adults. 
The puree did not affect the risk of a common cold or digestive tract infections. 
The circulating concentrations of isorhamnetin and quercetin were 
significantly elevated, but there were no effects on the plasma cholesterol or 
triacylglycerols.  
In the second clinical study of this thesis, the intake of 2 g of CO2-extracted sea 
buckthorn oil/day for 3 months significantly attenuated the rise of tear film 
osmolarity taking place during the cold season in participants with dry eye. 
The beneficial effects on dry eye symptoms were observed as well. The 
symptoms of redness and burning of eyes were milder in the participants of 
the sea buckthorn group compared to the placebo. Sea buckthorn oil did not 
affect the fatty acid composition of the tear film, indicating the effects may 
have been mediated via the modulation of inflammation rather than the 
incorporation of fatty acids from oral oil to the tear film. No effects on the 
circulating biomarkers of inflammation or aminotranferases were observed.  
These results suggest the positive effects of sea buckthorn berries and oil on 
inflammation and dry eye, respectively, in humans. The positive findings 
concerning the physiological effects of sea buckthorn berry and oils in animals 
and in humans deserve further investigation. There is especially a need for 
more large-scale clinical studies recruiting participants with special conditions 
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